microRNA information: hsa-miR-29a-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-29a-5p | miRbase |
| Accession: | MIMAT0004503 | miRbase |
| Precursor name: | hsa-mir-29a | miRbase |
| Precursor accession: | MI0000087 | miRbase |
| Symbol: | MIR29A | HGNC |
| RefSeq ID: | NR_029503 | GenBank |
| Sequence: | ACUGAUUUCUUUUGGUGUUCAG |
Reported expression in cancers: hsa-miR-29a-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-29a-5p | acute myeloid leukemia | downregulation | "miR 29a and miR 142 3p downregulation and diagnost ......" | 21678057 | Microarray; Northern blot; qPCR |
| hsa-miR-29a-5p | acute myeloid leukemia | downregulation | "MicroRNA 29a and microRNA 142 3p are regulators of ......" | 22493297 | |
| hsa-miR-29a-5p | acute myeloid leukemia | downregulation | "Prognostic value of miR 29a expression in pediatri ......" | 22981932 | qPCR |
| hsa-miR-29a-5p | acute myeloid leukemia | downregulation | "The role mechanism and potentially therapeutic app ......" | 24076586 | |
| hsa-miR-29a-5p | breast cancer | upregulation | "Among methods for profiling levels of miRNAs next- ......" | 22387599 | RNA-Seq; qPCR; Northern blot |
| hsa-miR-29a-5p | breast cancer | upregulation | "Then five up-regulated miRNAs miR-100 miR-29a miR- ......" | 23994196 | |
| hsa-miR-29a-5p | breast cancer | upregulation | "MiR 29a promotes cell proliferation and EMT in bre ......" | 27555295 | |
| hsa-miR-29a-5p | breast cancer | upregulation | "The aim of this study was to investigate the role ......" | 27746365 | qPCR |
| hsa-miR-29a-5p | colon cancer | upregulation | "Tumor microRNA 29a expression and the risk of recu ......" | 22426940 | Microarray; qPCR |
| hsa-miR-29a-5p | colorectal cancer | downregulation | "Two microRNAs miR-29a and miR-29c were disclosed a ......" | 22348113 | |
| hsa-miR-29a-5p | colorectal cancer | upregulation | "Quantitative reverse-transcription PCR was used to ......" | 23267864 | Reverse transcription PCR |
| hsa-miR-29a-5p | colorectal cancer | upregulation | "To assess the serum expression of 3 microRNA marke ......" | 25736690 | |
| hsa-miR-29a-5p | colorectal cancer | downregulation | "Fecal miR 29a and miR 224 as the noninvasive bioma ......" | 26756616 | |
| hsa-miR-29a-5p | esophageal cancer | downregulation | "MicroRNA miR-29a has been associated with carcinog ......" | 25435940 | |
| hsa-miR-29a-5p | glioblastoma | deregulation | "A number of changes in the levels of microRNAs wer ......" | 24155920 | |
| hsa-miR-29a-5p | kidney renal cell cancer | deregulation | "This study aims to profile dysregulated microRNA m ......" | 25938468 | Microarray |
| hsa-miR-29a-5p | liver cancer | downregulation | "Effects of microRNA 29 on apoptosis tumorigenicity ......" | 20041405 | Microarray; Northern blot; Reverse transcription PCR |
| hsa-miR-29a-5p | liver cancer | downregulation | "Modulation of miR 29 expression by α fetoprotein ......" | 24798303 | Microarray |
| hsa-miR-29a-5p | lung cancer | downregulation | "Recent studies of microRNA miRNA expression signat ......" | 27488440 | |
| hsa-miR-29a-5p | lung squamous cell cancer | deregulation | "Locked nucleic acids miRNA microarray expression p ......" | 20508945 | Microarray |
| hsa-miR-29a-5p | lung squamous cell cancer | deregulation | "Furthermore miR-29 overexpression downregulated β ......" | 23939044 | |
| hsa-miR-29a-5p | lymphoma | downregulation | "Notably expression levels of miR-29 family are ass ......" | 20086245 | |
| hsa-miR-29a-5p | ovarian cancer | deregulation | "The authors used quantitative polymerase chain rea ......" | 25556270 | qPCR |
| hsa-miR-29a-5p | prostate cancer | upregulation | "Epigenetic deregulation of miR 29a and miR 1256 by ......" | 22805767 | |
| hsa-miR-29a-5p | sarcoma | upregulation | "Furthermore the upregulated miRNAs included miR-9/ ......" | 23133552 |
Reported cancer pathway affected by hsa-miR-29a-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-29a-5p | acute myeloid leukemia | cell cycle pathway | "microRNA 29a induces aberrant self renewal capacit ......" | 20212066 | |
| hsa-miR-29a-5p | acute myeloid leukemia | Apoptosis pathway | "The role mechanism and potentially therapeutic app ......" | 24076586 | |
| hsa-miR-29a-5p | breast cancer | Apoptosis pathway | "MiR 222 and miR 29a contribute to the drug resista ......" | 23994196 | |
| hsa-miR-29a-5p | breast cancer | Apoptosis pathway | "Knockdown of microRNA 29a Changes the Expression o ......" | 26802653 | |
| hsa-miR-29a-5p | breast cancer | Apoptosis pathway | "MicroRNA 29a contributes to drug resistance of bre ......" | 27523474 | Western blot |
| hsa-miR-29a-5p | colorectal cancer | Apoptosis pathway | "Recent studies have suggested that microRNA-29 miR ......" | 25472644 | |
| hsa-miR-29a-5p | esophageal cancer | Notch signaling pathway | "miR 29a activates Hes1 by targeting Nfia in esopha ......" | 25435940 | |
| hsa-miR-29a-5p | gastric cancer | cell cycle pathway | "MiR 29a inhibits cell proliferation and induces ce ......" | 21998710 | |
| hsa-miR-29a-5p | glioblastoma | Apoptosis pathway | "Using this in vitro system a microarray-based high ......" | 24155920 | |
| hsa-miR-29a-5p | liver cancer | Apoptosis pathway | "Effects of microRNA 29 on apoptosis tumorigenicity ......" | 20041405 | |
| hsa-miR-29a-5p | lung squamous cell cancer | Wnt signaling pathway; Apoptosis pathway | "Suppression of Wnt signaling by the miR 29 family ......" | 23939044 | Western blot |
| hsa-miR-29a-5p | lymphoma | Apoptosis pathway | "MiR 29a down regulation in ALK positive anaplastic ......" | 21471522 | |
| hsa-miR-29a-5p | pancreatic cancer | Epithelial mesenchymal transition pathway | "MicroRNA 29a Promotes Pancreatic Cancer Growth by ......" | 26356262 | Western blot; Cell migration assay; MTT assay |
| hsa-miR-29a-5p | retinoblastoma | cell cycle pathway | "To investigate differential expression of microRNA ......" | 21941147 | |
| hsa-miR-29a-5p | sarcoma | cell cycle pathway | "In addition to CCND2 miR-29 also targets E2F7 anot ......" | 22330340 |
Reported cancer prognosis affected by hsa-miR-29a-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-29a-5p | acute myeloid leukemia | drug resistance | "Together the data support a tumor suppressor role ......" | 19850741 | |
| hsa-miR-29a-5p | acute myeloid leukemia | progression; differentiation | "microRNA 29a induces aberrant self renewal capacit ......" | 20212066 | |
| hsa-miR-29a-5p | acute myeloid leukemia | differentiation | "MicroRNA 29a and microRNA 142 3p are regulators of ......" | 22493297 | |
| hsa-miR-29a-5p | acute myeloid leukemia | poor survival; staging; worse prognosis | "Prognostic value of miR 29a expression in pediatri ......" | 22981932 | |
| hsa-miR-29a-5p | acute myeloid leukemia | differentiation | "The role mechanism and potentially therapeutic app ......" | 24076586 | |
| hsa-miR-29a-5p | acute myeloid leukemia | drug resistance | "microRNA-29 miR-29 family of non-coding small RNAs ......" | 26862847 | |
| hsa-miR-29a-5p | breast cancer | drug resistance | "Expression levels of miR-210 miR-21 miR-29a and mi ......" | 22370716 | |
| hsa-miR-29a-5p | breast cancer | differentiation; drug resistance | "Progestin suppression of miR 29 potentiates dediff ......" | 22751119 | |
| hsa-miR-29a-5p | breast cancer | drug resistance | "MiR 222 and miR 29a contribute to the drug resista ......" | 23994196 | |
| hsa-miR-29a-5p | breast cancer | tumorigenesis | "The inhibitory role of Mir 29 in growth of breast ......" | 24289849 | |
| hsa-miR-29a-5p | breast cancer | drug resistance | "MTT-cytotoxic miRNA microarray Real-time quantitat ......" | 25562151 | Western blot; Luciferase |
| hsa-miR-29a-5p | breast cancer | progression | "ADAM12 L is a direct target of the miR 29 and miR ......" | 25886595 | Western blot; Luciferase |
| hsa-miR-29a-5p | breast cancer | cell migration | "MicroRNA 29a inhibits cell migration and invasion ......" | 25955714 | |
| hsa-miR-29a-5p | breast cancer | drug resistance | "MicroRNA 29a contributes to drug resistance of bre ......" | 27523474 | Western blot |
| hsa-miR-29a-5p | breast cancer | metastasis; poor survival | "MiR 29a promotes cell proliferation and EMT in bre ......" | 27555295 | Luciferase |
| hsa-miR-29a-5p | breast cancer | worse prognosis; drug resistance | "The aim of this study was to investigate the role ......" | 27746365 | |
| hsa-miR-29a-5p | cervical and endocervical cancer | progression | "The oncogenic proteins E6 E7 and E5 expressed by H ......" | 23189617 | |
| hsa-miR-29a-5p | cervical and endocervical cancer | staging; progression | "An initial screening of miRNA expression was perfo ......" | 26171195 | |
| hsa-miR-29a-5p | colon cancer | staging; recurrence; poor survival | "Tumor microRNA 29a expression and the risk of recu ......" | 22426940 | |
| hsa-miR-29a-5p | colorectal cancer | staging | "We found that plasma miR-29a and miR-92a have sign ......" | 19876917 | |
| hsa-miR-29a-5p | colorectal cancer | recurrence | "Two microRNAs miR-29a and miR-29c were disclosed a ......" | 22348113 | |
| hsa-miR-29a-5p | colorectal cancer | staging | "Circulating miR 17 3p miR 29a miR 92a and miR 135b ......" | 23568010 | |
| hsa-miR-29a-5p | colorectal cancer | staging | "microRNA expression profile in stage III colorecta ......" | 23673725 | |
| hsa-miR-29a-5p | colorectal cancer | metastasis; worse prognosis | "MicroRNA 29a promotes colorectal cancer metastasis ......" | 24281002 | Western blot; Luciferase |
| hsa-miR-29a-5p | colorectal cancer | differentiation | "Recent studies have suggested that microRNA-29 miR ......" | 25472644 | |
| hsa-miR-29a-5p | colorectal cancer | malignant trasformation | "To assess the serum expression of 3 microRNA marke ......" | 25736690 | |
| hsa-miR-29a-5p | colorectal cancer | progression | "Downloading from GEO Gene Expression Omnibus datab ......" | 25755742 | |
| hsa-miR-29a-5p | endometrial cancer | malignant trasformation | "Expression profiling of normal and malignant endom ......" | 20028871 | |
| hsa-miR-29a-5p | esophageal cancer | tumorigenesis | "miR 29a activates Hes1 by targeting Nfia in esopha ......" | 25435940 | |
| hsa-miR-29a-5p | gastric cancer | metastasis | "The de-regulation of the miR-29 family and DNA met ......" | 25874772 | Transwell assay; Luciferase |
| hsa-miR-29a-5p | gastric cancer | cell migration | "Reduced miR 29a 3p expression is linked to the cel ......" | 25889078 | Western blot |
| hsa-miR-29a-5p | gastric cancer | cell migration | "MicroRNA 29a inhibits cell migration and invasion ......" | 25997819 | Western blot; Luciferase |
| hsa-miR-29a-5p | gastric cancer | worse prognosis | "Hsa miR 21 and Hsa miR 29 in Tissue as Potential D ......" | 26509997 | |
| hsa-miR-29a-5p | gastric cancer | drug resistance | "The expressions of the other two members of miR-29 ......" | 26564501 | |
| hsa-miR-29a-5p | gastric cancer | metastasis | "hTERT mediates gastric cancer metastasis partially ......" | 26903137 | |
| hsa-miR-29a-5p | glioblastoma | differentiation | "Using this in vitro system a microarray-based high ......" | 24155920 | |
| hsa-miR-29a-5p | glioblastoma | poor survival | "Feedback Loop Regulation of SCAP/SREBP 1 by miR 29 ......" | 27477273 | |
| hsa-miR-29a-5p | kidney renal cell cancer | staging | "This study aims to profile dysregulated microRNA m ......" | 25938468 | |
| hsa-miR-29a-5p | liver cancer | worse prognosis; malignant trasformation; tumorigenesis; poor survival | "Effects of microRNA 29 on apoptosis tumorigenicity ......" | 20041405 | |
| hsa-miR-29a-5p | liver cancer | malignant trasformation | "microRNA 29 can regulate expression of the long no ......" | 21625215 | |
| hsa-miR-29a-5p | liver cancer | recurrence; poor survival; staging | "MicroRNA 29a 5p is a novel predictor for early rec ......" | 23285022 | |
| hsa-miR-29a-5p | liver cancer | worse prognosis | "Modulation of miR 29 expression by α fetoprotein ......" | 24798303 | |
| hsa-miR-29a-5p | liver cancer | metastasis; progression; tumorigenesis | "Negative feedback of miR 29 family TET1 involves i ......" | 25367851 | |
| hsa-miR-29a-5p | liver cancer | metastasis; progression; tumorigenesis | "Erratum to: Negative feedback of miR 29 family TET ......" | 25616722 | |
| hsa-miR-29a-5p | lung cancer | worse prognosis | "MicroRNA 29 family reverts aberrant methylation in ......" | 17890317 | |
| hsa-miR-29a-5p | lung cancer | drug resistance; poor survival | "MicroRNA 29a regulates the benzoapyrene dihydrodio ......" | 23877787 | |
| hsa-miR-29a-5p | lung cancer | staging | "Regulation of LOXL2 and SERPINH1 by antitumor micr ......" | 27488440 | Luciferase |
| hsa-miR-29a-5p | lung squamous cell cancer | metastasis; progression; poor survival | "The dual role of the microRNA-29 miR-29 family in ......" | 24909176 | |
| hsa-miR-29a-5p | lung squamous cell cancer | cell migration | "Tumor suppressive microRNA 29 family inhibits canc ......" | 26676674 | Luciferase |
| hsa-miR-29a-5p | lymphoma | worse prognosis; poor survival | "microRNA expression profile and identification of ......" | 20086245 | |
| hsa-miR-29a-5p | lymphoma | poor survival; tumorigenesis | "MiR 29a down regulation in ALK positive anaplastic ......" | 21471522 | |
| hsa-miR-29a-5p | lymphoma | tumorigenesis | "Expression of MCL 1 and microRNA 29a in extranodal ......" | 23484699 | |
| hsa-miR-29a-5p | melanoma | staging; metastasis | "We hypothesized that the expression level of miR-2 ......" | 21081840 | |
| hsa-miR-29a-5p | ovarian cancer | drug resistance | "Downregulation of miR 29 contributes to cisplatin ......" | 23904094 | |
| hsa-miR-29a-5p | pancreatic cancer | drug resistance | "MicroRNA 29a induces resistance to gemcitabine thr ......" | 23900458 | |
| hsa-miR-29a-5p | pancreatic cancer | cell migration | "Micro RNAs miR 29a and miR 330 5p function as tumo ......" | 26036346 | |
| hsa-miR-29a-5p | pancreatic cancer | progression; tumorigenesis; metastasis | "MicroRNA 29a Promotes Pancreatic Cancer Growth by ......" | 26356262 | Western blot; Cell migration assay; MTT assay |
| hsa-miR-29a-5p | pancreatic cancer | drug resistance | "In particular modulations of let-7 miR-29a miR-17- ......" | 27539232 | |
| hsa-miR-29a-5p | pancreatic cancer | cell migration | "Novel role of miR 29a in pancreatic cancer autopha ......" | 27626694 | |
| hsa-miR-29a-5p | prostate cancer | progression | "Epigenetic deregulation of miR 29a and miR 1256 by ......" | 22805767 | Western blot |
| hsa-miR-29a-5p | prostate cancer | metastasis | "Herein we aimed to investigate the functional sign ......" | 24820027 | Luciferase |
| hsa-miR-29a-5p | sarcoma | differentiation | "NF kappaB YY1 miR 29 regulatory circuitry in skele ......" | 18977326 | |
| hsa-miR-29a-5p | sarcoma | progression | "The microRNA 29 plays a central role in osteosarco ......" | 23113351 | |
| hsa-miR-29a-5p | sarcoma | differentiation; tumorigenesis | "miR 29 acts as a decoy in sarcomas to protect the ......" | 23901138 | |
| hsa-miR-29a-5p | sarcoma | progression; differentiation | "Therefore in this review we focus on the regulatio ......" | 24831881 | |
| hsa-miR-29a-5p | sarcoma | progression; worse prognosis; metastasis; recurrence | "Prognostic value of the microRNA 29 family in pati ......" | 25015394 |
Reported gene related to hsa-miR-29a-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-29a-5p | bladder cancer | DNMT3A | "Mechanistically ATDC exerted its oncogenic effects ......" | 26471361 |
| hsa-miR-29a-5p | gastric cancer | DNMT3A | "The de-regulation of the miR-29 family and DNA met ......" | 25874772 |
| hsa-miR-29a-5p | liver cancer | DNMT3A | "Consistent with miR-29's role in targeting DNA met ......" | 24798303 |
| hsa-miR-29a-5p | lung cancer | DNMT3A | "Among the reported down-regulated miRNAs in lung c ......" | 17890317 |
| hsa-miR-29a-5p | lung squamous cell cancer | DNMT3A | "The miR-29 family miR-29a -29b and -29c which nega ......" | 23939044 |
| hsa-miR-29a-5p | lymphoma | DNMT3A | "DNMT3A and 3B genes can be regulated post-transcri ......" | 25746661 |
| hsa-miR-29a-5p | ovarian cancer | DNMT3A | "The miR-29 family and predicted target genes were ......" | 22479643 |
| hsa-miR-29a-5p | glioblastoma | MCL1 | "Finally miR-29a and miR-29b targeted MCL1 mRNA in ......" | 24155920 |
| hsa-miR-29a-5p | liver cancer | MCL1 | "Subsequent investigation characterized two antiapo ......" | 20041405 |
| hsa-miR-29a-5p | lymphoma | MCL1 | "MiR 29a down regulation in ALK positive anaplastic ......" | 21471522 |
| hsa-miR-29a-5p | lymphoma | MCL1 | "Expression of MCL 1 and microRNA 29a in extranodal ......" | 23484699 |
| hsa-miR-29a-5p | prostate cancer | MCL1 | "The identification of laminin gamma 1 LAMC1 and my ......" | 26052614 |
| hsa-miR-29a-5p | acute myeloid leukemia | CDK6 | "In addition a target of miR-29a cyclin-dependent k ......" | 22493297 |
| hsa-miR-29a-5p | lymphoma | CDK6 | "microRNA expression profile and identification of ......" | 20086245 |
| hsa-miR-29a-5p | melanoma | CDK6 | "The IFN-γ-induced G1-arrest of melanoma cells inv ......" | 23245396 |
| hsa-miR-29a-5p | liver cancer | DNMT3B | "TGF-β increased DNMT3B and DNMT1 and decreased mi ......" | 23789939 |
| hsa-miR-29a-5p | lung squamous cell cancer | DNMT3B | "The miR-29 family miR-29a -29b and -29c which nega ......" | 23939044 |
| hsa-miR-29a-5p | ovarian cancer | DNMT3B | "The miR-29 family and predicted target genes were ......" | 22479643 |
| hsa-miR-29a-5p | breast cancer | KLF4 | "Progestin suppression of miR 29 potentiates dediff ......" | 22751119 |
| hsa-miR-29a-5p | colorectal cancer | KLF4 | "KLF4 was identified as a direct target gene of miR ......" | 24281002 |
| hsa-miR-29a-5p | colorectal cancer | KLF4 | "Finally a transfection assay was performed to vali ......" | 22703586 |
| hsa-miR-29a-5p | bladder cancer | PTEN | "Mechanistically ATDC exerted its oncogenic effects ......" | 26471361 |
| hsa-miR-29a-5p | breast cancer | PTEN | "The most importance is that we identify two miRNAs ......" | 23994196 |
| hsa-miR-29a-5p | breast cancer | PTEN | "RT-qPCR and Western blot results showed that downr ......" | 27523474 |
| hsa-miR-29a-5p | breast cancer | TET1 | "Furthermore data from bioinformatic analysis valid ......" | 27555295 |
| hsa-miR-29a-5p | liver cancer | TET1 | "Negative feedback of miR 29 family TET1 involves i ......" | 25367851 |
| hsa-miR-29a-5p | liver cancer | TET1 | "Erratum to: Negative feedback of miR 29 family TET ......" | 25616722 |
| hsa-miR-29a-5p | gastric cancer | CCND2 | "We further demonstrated that miR-29 family acted a ......" | 24130168 |
| hsa-miR-29a-5p | sarcoma | CCND2 | "In addition to CCND2 miR-29 also targets E2F7 anot ......" | 22330340 |
| hsa-miR-29a-5p | liver cancer | DNMT1 | "MiRNA-dependent regulation of MEG3 expression was ......" | 21625215 |
| hsa-miR-29a-5p | liver cancer | DNMT1 | "Recent studies have shown that the epigenetic regu ......" | 23789939 |
| hsa-miR-29a-5p | lung cancer | LOXL2 | "Regulation of LOXL2 and SERPINH1 by antitumor micr ......" | 27488440 |
| hsa-miR-29a-5p | lung squamous cell cancer | LOXL2 | "Tumor suppressive microRNA 29 family inhibits canc ......" | 26676674 |
| hsa-miR-29a-5p | lung cancer | SCLC1 | "Two microRNA panels yielded high diagnostic accura ......" | 23043084 |
| hsa-miR-29a-5p | lung squamous cell cancer | SCLC1 | "Because microRNAs miRNA often act as tumor regulat ......" | 23966614 |
| hsa-miR-29a-5p | breast cancer | SLC10A4 | "We demonstrate that P4 rapidly downregulates miR-2 ......" | 22751119 |
| hsa-miR-29a-5p | breast cancer | SLC10A4 | "We previously described that P4 downregulation of ......" | 25241899 |
| hsa-miR-29a-5p | breast cancer | ADAM12 | "ADAM12 L is a direct target of the miR 29 and miR ......" | 25886595 |
| hsa-miR-29a-5p | liver cancer | AFP | "Overexpression of AFP or conditioned media from AF ......" | 24798303 |
| hsa-miR-29a-5p | breast cancer | AKR1B1 | "Our previous microarray found that miR-29a may str ......" | 27523474 |
| hsa-miR-29a-5p | acute myeloid leukemia | AKT2 | "Furthermore a feed-back loop comprising of c-Myc m ......" | 24076586 |
| hsa-miR-29a-5p | lymphoma | ALK | "MiR 29a down regulation in ALK positive anaplastic ......" | 21471522 |
| hsa-miR-29a-5p | prostate cancer | AR | "A direct AR regulation of miR-22 miR-29a and miR-1 ......" | 26052614 |
| hsa-miR-29a-5p | acute myeloid leukemia | ARHGEF1 | "miR-29a is overexpressed in human AML and like hum ......" | 20212066 |
| hsa-miR-29a-5p | cervical and endocervical cancer | ARHGEF15 | "The oncogenic proteins E6 E7 and E5 expressed by H ......" | 23189617 |
| hsa-miR-29a-5p | pancreatic cancer | ATG9A | "In addition miR-29a decreased the expression of au ......" | 27626694 |
| hsa-miR-29a-5p | breast cancer | ATP1B1 | "Many progestin-responsive genes are putative targe ......" | 22330642 |
| hsa-miR-29a-5p | liver cancer | BCL2 | "Subsequent investigation characterized two antiapo ......" | 20041405 |
| hsa-miR-29a-5p | ovarian cancer | CASP3 | "When combined with cisplatin treatment knockdown o ......" | 23904094 |
| hsa-miR-29a-5p | ovarian cancer | CASP9 | "When combined with cisplatin treatment knockdown o ......" | 23904094 |
| hsa-miR-29a-5p | gastric cancer | CDC37 | "MicroRNA 29a inhibits cell migration and invasion ......" | 25997819 |
| hsa-miR-29a-5p | gastric cancer | CDC42 | "This study was designed to investigate the effect ......" | 20507733 |
| hsa-miR-29a-5p | lung cancer | CDC7 | "MicroRNA 29a regulates the benzoapyrene dihydrodio ......" | 23877787 |
| hsa-miR-29a-5p | liver cancer | CDH1 | "Recent studies have shown that the epigenetic regu ......" | 23789939 |
| hsa-miR-29a-5p | lung cancer | CEACAM5 | "MicroRNA 29a suppresses the growth migration and i ......" | 25171863 |
| hsa-miR-29a-5p | lung cancer | CEACAM6 | "Furthermore miR-29a can suppress the growth migrat ......" | 25171863 |
| hsa-miR-29a-5p | prostate cancer | CX3CL1 | "MicroRNA software predicted that miR21 targets VCL ......" | 27509989 |
| hsa-miR-29a-5p | lung cancer | DBF4 | "In silico analysis identified microRNA-29 miR-29-b ......" | 23877787 |
| hsa-miR-29a-5p | breast cancer | DICER1 | "MiR-222/221 which target ESR1 itself and miR-29a a ......" | 21761362 |
| hsa-miR-29a-5p | sarcoma | E2F7 | "In addition to CCND2 miR-29 also targets E2F7 anot ......" | 22330340 |
| hsa-miR-29a-5p | glioblastoma | EGFR | "Feedback Loop Regulation of SCAP/SREBP 1 by miR 29 ......" | 27477273 |
| hsa-miR-29a-5p | sarcoma | ELAVL1 | "miR 29 acts as a decoy in sarcomas to protect the ......" | 23901138 |
| hsa-miR-29a-5p | thyroid cancer | EPHA3 | "Second the direct interaction between one of the u ......" | 25153510 |
| hsa-miR-29a-5p | breast cancer | ESR1 | "MiR-222/221 which target ESR1 itself and miR-29a a ......" | 21761362 |
| hsa-miR-29a-5p | B cell lymphoma | EZH2 | "Combined inhibition of HDAC3 and EZH2 cooperativel ......" | 23079660 |
| hsa-miR-29a-5p | lung squamous cell cancer | FRTS1 | "Evidence for the role of miR-29 in tumor malignanc ......" | 24909176 |
| hsa-miR-29a-5p | acute myeloid leukemia | FUT1 | "We show that miR-29a is highly expressed in HSC an ......" | 20212066 |
| hsa-miR-29a-5p | pancreatic cancer | GEM | "The aim of this study was to investigate the relat ......" | 23900458 |
| hsa-miR-29a-5p | acute myeloid leukemia | GLI2 | "Overexpression of each miR-29 member in THP1 and N ......" | 24076586 |
| hsa-miR-29a-5p | B cell lymphoma | HDAC3 | "Combined inhibition of HDAC3 and EZH2 cooperativel ......" | 23079660 |
| hsa-miR-29a-5p | esophageal cancer | HES1 | "miR 29a activates Hes1 by targeting Nfia in esopha ......" | 25435940 |
| hsa-miR-29a-5p | gastric cancer | ITGA9 | "We found that the up-regulation of hTERT in gastri ......" | 26903137 |
| hsa-miR-29a-5p | gastric cancer | ITGB1 | "hTERT mediates gastric cancer metastasis partially ......" | 26903137 |
| hsa-miR-29a-5p | prostate cancer | LAMC1 | "The identification of laminin gamma 1 LAMC1 and my ......" | 26052614 |
| hsa-miR-29a-5p | pancreatic cancer | LOC100508689 | "Altogether we have identified miR-29a and miR-330- ......" | 26036346 |
| hsa-miR-29a-5p | thyroid cancer | LOX | "Second the direct interaction between one of the u ......" | 25153510 |
| hsa-miR-29a-5p | pancreatic cancer | MAP1LC3B | "Furthermore miR-29a blocked autophagy flux as evid ......" | 27626694 |
| hsa-miR-29a-5p | liver cancer | MEG3 | "microRNA 29 can regulate expression of the long no ......" | 21625215 |
| hsa-miR-29a-5p | gastric cancer | MMP2 | "We further demonstrated that miR-29 family acted a ......" | 24130168 |
| hsa-miR-29a-5p | pancreatic cancer | MMRN1 | "Loss of miR-29 is correlated with a significant in ......" | 26095125 |
| hsa-miR-29a-5p | pancreatic cancer | MUC1 | "Our in vitro and in vivo experiments indicate that ......" | 26036346 |
| hsa-miR-29a-5p | breast cancer | MYBL2 | "We further found that Mir-29a negatively regulated ......" | 24289849 |
| hsa-miR-29a-5p | acute myeloid leukemia | MYC | "Furthermore a feed-back loop comprising of c-Myc m ......" | 24076586 |
| hsa-miR-29a-5p | esophageal cancer | NFIA | "miR 29a activates Hes1 by targeting Nfia in esopha ......" | 25435940 |
| hsa-miR-29a-5p | sarcoma | NFKB1 | "Results demonstrate that in myoblasts miR-29 is re ......" | 18977326 |
| hsa-miR-29a-5p | breast cancer | NMI | "Luciferase reporter assays and western blot analys ......" | 25174825 |
| hsa-miR-29a-5p | esophageal cancer | NOTCH1 | "miR-29a overexpression did not affect the expressi ......" | 25435940 |
| hsa-miR-29a-5p | acute myeloid leukemia | NPM1 | "Furthermore our data showed that deregulated expre ......" | 21880628 |
| hsa-miR-29a-5p | gastric cancer | PAK1 | "Similar to si-Cdc42 the ectopic expression of micr ......" | 20507733 |
| hsa-miR-29a-5p | gastric cancer | ROBO1 | "MicroRNA 29a inhibits cell migration and invasion ......" | 25997819 |
| hsa-miR-29a-5p | gastric cancer | SAPCD2 | "MiR 29a inhibits cell proliferation and induces ce ......" | 21998710 |
| hsa-miR-29a-5p | glioblastoma | SCAP | "Here we unraveled a link between miR-29 and the SC ......" | 27477273 |
| hsa-miR-29a-5p | lung cancer | SERPINH1 | "Regulation of LOXL2 and SERPINH1 by antitumor micr ......" | 27488440 |
| hsa-miR-29a-5p | pancreatic cancer | SMAD3 | "Furthermore the loss of miR-29 in TGF-β1 activate ......" | 26095125 |
| hsa-miR-29a-5p | retinoblastoma | SOX5 | "Loop network analysis revealed a regulatory associ ......" | 25232279 |
| hsa-miR-29a-5p | liver cancer | SPARC | "microRNA 29a suppresses cell proliferation by targ ......" | 23023935 |
| hsa-miR-29a-5p | melanoma | STAT1 | "Interferon γ induced activation of Signal Transdu ......" | 23245396 |
| hsa-miR-29a-5p | pancreatic cancer | TFEB | "In addition miR-29a decreased the expression of au ......" | 27626694 |
| hsa-miR-29a-5p | prostate cancer | TNF | "Tumor necrosis factor receptor associated factor 4 ......" | 24100420 |
| hsa-miR-29a-5p | prostate cancer | TOLLIP | "Tumor necrosis factor receptor associated factor 4 ......" | 24100420 |
| hsa-miR-29a-5p | prostate cancer | TRAF4 | "We initially identified microRNA-29a miR‑29a as ......" | 24100420 |
| hsa-miR-29a-5p | melanoma | TRG | "We hypothesized that the expression level of miR-2 ......" | 21081840 |
| hsa-miR-29a-5p | prostate cancer | TRIM68 | "The increased levels of miR-29a and miR-1256 by is ......" | 22805767 |
| hsa-miR-29a-5p | liver cancer | TTR | "MiR-29a-5p level was significantly associated with ......" | 23285022 |
| hsa-miR-29a-5p | sarcoma | TUT1 | "Nucleotidyl transferase TUT1 inhibits lipogenesis ......" | 25142229 |
| hsa-miR-29a-5p | prostate cancer | VCL | "MicroRNA software predicted that miR21 targets VCL ......" | 27509989 |
| hsa-miR-29a-5p | gastric cancer | VEGFA | "miR 29a suppresses growth and invasion of gastric ......" | 24209632 |
| hsa-miR-29a-5p | lung squamous cell cancer | WIF1 | "Suppression of Wnt signaling by the miR 29 family ......" | 23939044 |
| hsa-miR-29a-5p | pancreatic cancer | WNT3A | "We also examined the effect of miR-29a on the Wnt/ ......" | 23900458 |
| hsa-miR-29a-5p | sarcoma | YY1 | "Results demonstrate that in myoblasts miR-29 is re ......" | 18977326 |
| hsa-miR-29a-5p | pancreatic cancer | ZFP36 | "MicroRNA 29a Promotes Pancreatic Cancer Growth by ......" | 26356262 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-29a-5p | HLF | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.561; TCGA BRCA -0.201; TCGA COAD -0.261; TCGA ESCA -0.552; TCGA HNSC -0.421; TCGA KIRC -0.272; TCGA LUAD -0.249; TCGA SARC -0.843; TCGA THCA -0.53; TCGA STAD -1.025 |
hsa-miR-29a-5p | PRRC1 | 9 cancers: BLCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; mirMAP | TCGA BLCA -0.071; TCGA HNSC -0.076; TCGA KIRP -0.125; TCGA LGG -0.128; TCGA LUAD -0.072; TCGA LUSC -0.051; TCGA PAAD -0.116; TCGA PRAD -0.114; TCGA THCA -0.108 |
hsa-miR-29a-5p | FAM117B | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; UCEC | MirTarget | TCGA BLCA -0.159; TCGA CESC -0.179; TCGA HNSC -0.135; TCGA KIRP -0.126; TCGA LIHC -0.123; TCGA LUAD -0.099; TCGA LUSC -0.168; TCGA SARC -0.148; TCGA UCEC -0.055 |
hsa-miR-29a-5p | HINT3 | 10 cancers: BLCA; CESC; HNSC; KIRP; LUAD; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.18; TCGA CESC -0.087; TCGA HNSC -0.089; TCGA KIRP -0.108; TCGA LUAD -0.091; TCGA PAAD -0.131; TCGA SARC -0.099; TCGA THCA -0.082; TCGA STAD -0.133; TCGA UCEC -0.057 |
hsa-miR-29a-5p | LRCH2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; SARC; STAD | MirTarget | TCGA BLCA -0.216; TCGA BRCA -0.166; TCGA COAD -0.847; TCGA ESCA -0.348; TCGA HNSC -0.246; TCGA KIRP -0.507; TCGA LGG -0.124; TCGA LUAD -0.153; TCGA SARC -0.395; TCGA STAD -0.668 |
hsa-miR-29a-5p | FLT1 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; THCA; STAD | MirTarget | TCGA BLCA -0.124; TCGA BRCA -0.068; TCGA COAD -0.254; TCGA HNSC -0.197; TCGA KIRC -0.586; TCGA KIRP -0.245; TCGA LIHC -0.21; TCGA LUAD -0.175; TCGA THCA -0.242; TCGA STAD -0.128 |
hsa-miR-29a-5p | MSL2 | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.079; TCGA CESC -0.117; TCGA HNSC -0.081; TCGA KIRP -0.123; TCGA LGG -0.084; TCGA LIHC -0.09; TCGA LUAD -0.067; TCGA PRAD -0.068; TCGA SARC -0.072; TCGA THCA -0.092 |
hsa-miR-29a-5p | SMAD9 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.711; TCGA COAD -0.618; TCGA ESCA -0.604; TCGA HNSC -0.586; TCGA KIRP -0.463; TCGA LGG -0.173; TCGA LIHC -0.25; TCGA LUAD -0.417; TCGA LUSC -0.313; TCGA PRAD -0.295; TCGA SARC -0.563; TCGA THCA -0.772; TCGA STAD -0.883 |
hsa-miR-29a-5p | FYCO1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; PRAD; SARC; THCA; STAD | MirTarget; mirMAP | TCGA BLCA -0.27; TCGA BRCA -0.094; TCGA COAD -0.155; TCGA ESCA -0.187; TCGA HNSC -0.221; TCGA PRAD -0.137; TCGA SARC -0.276; TCGA THCA -0.187; TCGA STAD -0.339 |
hsa-miR-29a-5p | ATP11B | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; THCA | MirTarget | TCGA BLCA -0.085; TCGA CESC -0.296; TCGA ESCA -0.176; TCGA HNSC -0.227; TCGA KIRP -0.206; TCGA LIHC -0.243; TCGA LUAD -0.122; TCGA PRAD -0.166; TCGA THCA -0.122 |
hsa-miR-29a-5p | KIAA0430 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PRAD; SARC; STAD | MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.167; TCGA CESC -0.082; TCGA COAD -0.102; TCGA HNSC -0.109; TCGA KIRP -0.13; TCGA LUAD -0.079; TCGA PRAD -0.097; TCGA SARC -0.14; TCGA STAD -0.147 |
hsa-miR-29a-5p | NF1 | 10 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.129; TCGA CESC -0.127; TCGA HNSC -0.157; TCGA KIRP -0.145; TCGA LIHC -0.155; TCGA LUAD -0.082; TCGA LUSC -0.121; TCGA PRAD -0.134; TCGA SARC -0.13; TCGA THCA -0.125 |
hsa-miR-29a-5p | LATS1 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.175; TCGA CESC -0.299; TCGA COAD -0.136; TCGA HNSC -0.335; TCGA KIRP -0.359; TCGA LIHC -0.155; TCGA LUAD -0.205; TCGA LUSC -0.109; TCGA PRAD -0.295; TCGA SARC -0.176; TCGA THCA -0.361; TCGA STAD -0.098 |
hsa-miR-29a-5p | PPM1A | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; SARC; THCA; STAD | MirTarget; mirMAP; miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.073; TCGA CESC -0.092; TCGA COAD -0.052; TCGA HNSC -0.059; TCGA LIHC -0.107; TCGA LUAD -0.098; TCGA SARC -0.086; TCGA THCA -0.107; TCGA STAD -0.161 |
hsa-miR-29a-5p | AXIN2 | 9 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.371; TCGA BRCA -0.207; TCGA HNSC -0.258; TCGA LUAD -0.133; TCGA LUSC -0.279; TCGA PRAD -0.081; TCGA SARC -0.285; TCGA THCA -0.123; TCGA STAD -0.191 |
hsa-miR-29a-5p | HEY1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; STAD; UCEC | MirTarget | TCGA BLCA -0.158; TCGA BRCA -0.157; TCGA CESC -0.375; TCGA COAD -0.25; TCGA ESCA -0.381; TCGA KIRC -0.403; TCGA KIRP -0.674; TCGA LGG -0.378; TCGA LUAD -0.186; TCGA STAD -0.145; TCGA UCEC -0.273 |
hsa-miR-29a-5p | SSBP2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.139; TCGA BRCA -0.147; TCGA CESC -0.164; TCGA COAD -0.523; TCGA ESCA -0.611; TCGA KIRP -0.171; TCGA LIHC -0.336; TCGA LUAD -0.11; TCGA PRAD -0.075; TCGA SARC -0.351; TCGA STAD -0.53; TCGA UCEC -0.123 |
hsa-miR-29a-5p | ZCCHC24 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.158; TCGA BRCA -0.324; TCGA COAD -0.387; TCGA ESCA -0.509; TCGA HNSC -0.192; TCGA LGG -0.139; TCGA LUAD -0.116; TCGA PAAD -0.443; TCGA THCA -0.055; TCGA STAD -0.611 |
hsa-miR-29a-5p | MANEA | 9 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.097; TCGA CESC -0.212; TCGA HNSC -0.143; TCGA KIRP -0.254; TCGA LUAD -0.151; TCGA LUSC -0.076; TCGA PRAD -0.226; TCGA SARC -0.132; TCGA THCA -0.193 |
hsa-miR-29a-5p | NEDD9 | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.116; TCGA BRCA -0.12; TCGA COAD -0.325; TCGA KIRC -0.22; TCGA KIRP -0.191; TCGA LUAD -0.145; TCGA PAAD -0.184; TCGA PRAD -0.113; TCGA SARC -0.141; TCGA THCA -0.127; TCGA UCEC -0.108 |
hsa-miR-29a-5p | ARIH1 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget; mirMAP | TCGA BLCA -0.099; TCGA CESC -0.099; TCGA COAD -0.061; TCGA HNSC -0.083; TCGA KIRP -0.132; TCGA LUAD -0.075; TCGA PAAD -0.103; TCGA PRAD -0.101; TCGA SARC -0.073; TCGA THCA -0.077; TCGA STAD -0.095 |
hsa-miR-29a-5p | REST | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.249; TCGA CESC -0.386; TCGA COAD -0.14; TCGA HNSC -0.389; TCGA KIRP -0.479; TCGA LIHC -0.255; TCGA LUAD -0.162; TCGA LUSC -0.116; TCGA PRAD -0.313; TCGA SARC -0.246; TCGA THCA -0.431 |
hsa-miR-29a-5p | FADS1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.144; TCGA CESC -0.238; TCGA COAD -0.297; TCGA ESCA -0.321; TCGA HNSC -0.16; TCGA LGG -0.111; TCGA LUAD -0.111; TCGA PRAD -0.175; TCGA THCA -0.108; TCGA STAD -0.246 |
hsa-miR-29a-5p | ZXDB | 9 cancers: BLCA; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.107; TCGA HNSC -0.103; TCGA KIRP -0.112; TCGA LGG -0.053; TCGA LUAD -0.126; TCGA PRAD -0.132; TCGA SARC -0.152; TCGA THCA -0.157; TCGA STAD -0.124 |
hsa-miR-29a-5p | MKX | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.262; TCGA COAD -0.361; TCGA ESCA -0.687; TCGA HNSC -0.299; TCGA KIRP -0.363; TCGA LUAD -0.2; TCGA LUSC -0.298; TCGA PAAD -0.455; TCGA PRAD -0.106; TCGA SARC -0.617; TCGA STAD -0.843 |
hsa-miR-29a-5p | ATF2 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.107; TCGA CESC -0.215; TCGA COAD -0.12; TCGA HNSC -0.217; TCGA KIRP -0.28; TCGA LUAD -0.099; TCGA LUSC -0.065; TCGA PRAD -0.242; TCGA SARC -0.164; TCGA THCA -0.344; TCGA STAD -0.088 |
hsa-miR-29a-5p | TMEM170B | 10 cancers: BLCA; CESC; COAD; HNSC; LIHC; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.314; TCGA CESC -0.192; TCGA COAD -0.221; TCGA HNSC -0.223; TCGA LIHC -0.237; TCGA LUAD -0.12; TCGA PAAD -0.253; TCGA PRAD -0.122; TCGA THCA -0.217; TCGA STAD -0.532 |
hsa-miR-29a-5p | MAPT | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.548; TCGA BRCA -0.54; TCGA CESC -0.427; TCGA COAD -0.575; TCGA ESCA -0.906; TCGA KIRC -0.532; TCGA LUSC -0.209; TCGA PRAD -0.132; TCGA SARC -0.524; TCGA THCA -0.317; TCGA STAD -0.864 |
hsa-miR-29a-5p | KDM3B | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.131; TCGA CESC -0.101; TCGA HNSC -0.146; TCGA KIRP -0.137; TCGA LGG -0.098; TCGA LUAD -0.081; TCGA LUSC -0.072; TCGA PRAD -0.089; TCGA SARC -0.14; TCGA THCA -0.097 |
hsa-miR-29a-5p | DENND4A | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.128; TCGA CESC -0.172; TCGA COAD -0.155; TCGA HNSC -0.18; TCGA KIRP -0.151; TCGA LUAD -0.173; TCGA PAAD -0.194; TCGA PRAD -0.132; TCGA THCA -0.209; TCGA STAD -0.088 |
hsa-miR-29a-5p | RNF111 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; THCA | MirTarget | TCGA BLCA -0.124; TCGA CESC -0.163; TCGA COAD -0.127; TCGA HNSC -0.158; TCGA KIRP -0.119; TCGA LIHC -0.086; TCGA LUAD -0.082; TCGA PRAD -0.159; TCGA THCA -0.117 |
hsa-miR-29a-5p | PPM1D | 15 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.118; TCGA CESC -0.224; TCGA COAD -0.082; TCGA HNSC -0.146; TCGA KIRC -0.156; TCGA KIRP -0.173; TCGA LGG -0.13; TCGA LIHC -0.178; TCGA LUAD -0.191; TCGA LUSC -0.138; TCGA PAAD -0.14; TCGA PRAD -0.129; TCGA SARC -0.147; TCGA THCA -0.152; TCGA UCEC -0.067 |
hsa-miR-29a-5p | SBNO1 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.194; TCGA CESC -0.353; TCGA HNSC -0.334; TCGA KIRP -0.408; TCGA LIHC -0.218; TCGA LUAD -0.169; TCGA PRAD -0.336; TCGA SARC -0.187; TCGA THCA -0.512 |
hsa-miR-29a-5p | ZNF709 | 9 cancers: BLCA; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.208; TCGA KIRP -0.094; TCGA LGG -0.082; TCGA LIHC -0.148; TCGA LUAD -0.065; TCGA PRAD -0.097; TCGA SARC -0.079; TCGA THCA -0.077; TCGA STAD -0.052 |
hsa-miR-29a-5p | WBSCR17 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; PAAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.221; TCGA BRCA -0.17; TCGA COAD -0.772; TCGA ESCA -0.745; TCGA LUAD -0.275; TCGA PAAD -0.509; TCGA SARC -1.206; TCGA THCA -0.547; TCGA STAD -0.603 |
hsa-miR-29a-5p | PTPRG | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.16; TCGA BRCA -0.113; TCGA COAD -0.123; TCGA HNSC -0.272; TCGA KIRC -0.132; TCGA KIRP -0.258; TCGA LUAD -0.306; TCGA LUSC -0.257; TCGA PAAD -0.293; TCGA PRAD -0.251; TCGA THCA -0.25; TCGA UCEC -0.098 |
hsa-miR-29a-5p | ANKRD50 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.225; TCGA BRCA -0.131; TCGA CESC -0.202; TCGA COAD -0.191; TCGA ESCA -0.248; TCGA HNSC -0.215; TCGA KIRP -0.165; TCGA LUAD -0.086; TCGA PAAD -0.209; TCGA PRAD -0.175; TCGA SARC -0.362; TCGA THCA -0.263; TCGA STAD -0.234 |
hsa-miR-29a-5p | ABL1 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.115; TCGA BRCA -0.071; TCGA ESCA -0.126; TCGA HNSC -0.103; TCGA KIRC -0.071; TCGA LGG -0.111; TCGA PAAD -0.125; TCGA SARC -0.121; TCGA THCA -0.055; TCGA STAD -0.211 |
hsa-miR-29a-5p | AGAP1 | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; PAAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.103; TCGA CESC -0.152; TCGA HNSC -0.167; TCGA KIRC -0.091; TCGA KIRP -0.132; TCGA PAAD -0.176; TCGA SARC -0.096; TCGA THCA -0.06; TCGA STAD -0.102 |
hsa-miR-29a-5p | ZNF654 | 10 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; UCEC | MirTarget; mirMAP | TCGA BLCA -0.128; TCGA CESC -0.094; TCGA HNSC -0.066; TCGA KIRP -0.131; TCGA LIHC -0.096; TCGA LUAD -0.089; TCGA PRAD -0.13; TCGA SARC -0.098; TCGA THCA -0.109; TCGA UCEC -0.107 |
hsa-miR-29a-5p | SESN3 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | MirTarget; mirMAP | TCGA BLCA -0.233; TCGA COAD -0.302; TCGA ESCA -0.776; TCGA HNSC -0.316; TCGA KIRP -0.328; TCGA LIHC -0.409; TCGA LUAD -0.218; TCGA PRAD -0.367; TCGA SARC -0.135; TCGA THCA -0.449; TCGA STAD -0.511 |
hsa-miR-29a-5p | SBF2 | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.153; TCGA CESC -0.116; TCGA HNSC -0.169; TCGA KIRP -0.154; TCGA LGG -0.125; TCGA LUAD -0.182; TCGA PRAD -0.163; TCGA SARC -0.102; TCGA THCA -0.113; TCGA STAD -0.176 |
hsa-miR-29a-5p | ZFX | 10 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.123; TCGA CESC -0.145; TCGA HNSC -0.162; TCGA KIRP -0.202; TCGA LIHC -0.258; TCGA LUAD -0.101; TCGA PRAD -0.166; TCGA SARC -0.195; TCGA THCA -0.223; TCGA STAD -0.114 |
hsa-miR-29a-5p | ATRX | 13 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.177; TCGA CESC -0.094; TCGA COAD -0.069; TCGA HNSC -0.168; TCGA KIRP -0.169; TCGA LGG -0.118; TCGA LUAD -0.117; TCGA LUSC -0.112; TCGA PRAD -0.149; TCGA SARC -0.124; TCGA THCA -0.174; TCGA STAD -0.115; TCGA UCEC -0.07 |
hsa-miR-29a-5p | MYOCD | 11 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.762; TCGA BRCA -0.308; TCGA COAD -1.069; TCGA ESCA -0.665; TCGA LIHC -0.384; TCGA LUAD -0.555; TCGA PAAD -0.527; TCGA PRAD -0.393; TCGA SARC -1.762; TCGA THCA -0.29; TCGA STAD -1.151 |
hsa-miR-29a-5p | RAPGEF4 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.23; TCGA BRCA -0.082; TCGA CESC -0.184; TCGA COAD -0.211; TCGA HNSC -0.163; TCGA KIRC -0.506; TCGA KIRP -0.364; TCGA LIHC -0.287; TCGA LUAD -0.285; TCGA LUSC -0.207; TCGA SARC -0.28; TCGA THCA -0.165; TCGA STAD -0.236 |
hsa-miR-29a-5p | SHE | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.228; TCGA BRCA -0.221; TCGA COAD -0.611; TCGA HNSC -0.282; TCGA KIRC -0.231; TCGA KIRP -0.423; TCGA LUAD -0.256; TCGA PAAD -0.428; TCGA SARC -0.136; TCGA STAD -0.405 |
hsa-miR-29a-5p | CDON | 11 cancers: BLCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.219; TCGA COAD -0.318; TCGA HNSC -0.188; TCGA KIRC -0.306; TCGA LGG -0.147; TCGA LUAD -0.274; TCGA PAAD -0.252; TCGA PRAD -0.228; TCGA SARC -0.225; TCGA THCA -0.529; TCGA STAD -0.705 |
hsa-miR-29a-5p | COL4A3BP | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.098; TCGA BRCA -0.095; TCGA COAD -0.06; TCGA HNSC -0.06; TCGA LUAD -0.131; TCGA PRAD -0.107; TCGA SARC -0.089; TCGA THCA -0.102; TCGA STAD -0.1; TCGA UCEC -0.083 |
hsa-miR-29a-5p | JMY | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.266; TCGA CESC -0.151; TCGA COAD -0.127; TCGA ESCA -0.314; TCGA HNSC -0.164; TCGA KIRP -0.168; TCGA LUAD -0.125; TCGA PRAD -0.082; TCGA SARC -0.218; TCGA STAD -0.319 |
hsa-miR-29a-5p | ARL5B | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA | MirTarget; mirMAP | TCGA BLCA -0.108; TCGA CESC -0.19; TCGA HNSC -0.205; TCGA KIRP -0.305; TCGA LIHC -0.158; TCGA LUAD -0.144; TCGA LUSC -0.144; TCGA PRAD -0.237; TCGA THCA -0.307 |
hsa-miR-29a-5p | PARD3B | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.495; TCGA COAD -0.231; TCGA HNSC -0.386; TCGA KIRP -0.536; TCGA LUAD -0.233; TCGA PAAD -0.506; TCGA PRAD -0.247; TCGA SARC -0.448; TCGA THCA -0.411; TCGA STAD -0.254 |
hsa-miR-29a-5p | NCOR1 | 9 cancers: BLCA; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.121; TCGA COAD -0.083; TCGA HNSC -0.196; TCGA KIRP -0.26; TCGA LIHC -0.2; TCGA LUAD -0.156; TCGA PRAD -0.139; TCGA SARC -0.254; TCGA THCA -0.208 |
hsa-miR-29a-5p | FRZB | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.352; TCGA BRCA -0.194; TCGA COAD -0.718; TCGA HNSC -0.295; TCGA KIRC -0.431; TCGA LIHC -0.247; TCGA LUAD -0.186; TCGA LUSC -0.243; TCGA PAAD -0.419; TCGA SARC -0.481; TCGA THCA -0.162; TCGA STAD -0.672 |
hsa-miR-29a-5p | KCNIP4 | 9 cancers: BLCA; COAD; KIRC; KIRP; LUAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.219; TCGA COAD -0.11; TCGA KIRC -0.155; TCGA KIRP -0.361; TCGA LUAD -0.172; TCGA PRAD -0.071; TCGA THCA -0.339; TCGA STAD -0.388; TCGA UCEC -0.119 |
hsa-miR-29a-5p | PIK3C2A | 11 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.142; TCGA CESC -0.098; TCGA HNSC -0.147; TCGA KIRP -0.171; TCGA LIHC -0.122; TCGA LUAD -0.124; TCGA PAAD -0.141; TCGA PRAD -0.173; TCGA SARC -0.133; TCGA THCA -0.216; TCGA STAD -0.091 |
hsa-miR-29a-5p | ARID2 | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.217; TCGA CESC -0.144; TCGA HNSC -0.156; TCGA KIRP -0.093; TCGA LGG -0.109; TCGA LIHC -0.149; TCGA LUAD -0.155; TCGA PRAD -0.099; TCGA SARC -0.122; TCGA THCA -0.087 |
hsa-miR-29a-5p | SASH1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; THCA; STAD | MirTarget; mirMAP | TCGA BLCA -0.296; TCGA CESC -0.315; TCGA COAD -0.207; TCGA ESCA -0.257; TCGA HNSC -0.387; TCGA LUAD -0.284; TCGA PAAD -0.24; TCGA THCA -0.238; TCGA STAD -0.326 |
hsa-miR-29a-5p | CACNB2 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; SARC; STAD | MirTarget | TCGA BLCA -0.557; TCGA COAD -0.281; TCGA ESCA -0.382; TCGA HNSC -0.152; TCGA KIRC -0.343; TCGA LIHC -0.216; TCGA LUAD -0.152; TCGA SARC -0.834; TCGA STAD -0.82 |
hsa-miR-29a-5p | FAT4 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.352; TCGA BRCA -0.239; TCGA COAD -0.683; TCGA ESCA -0.274; TCGA HNSC -0.405; TCGA KIRC -0.167; TCGA KIRP -0.478; TCGA LUAD -0.289; TCGA LUSC -0.235; TCGA PAAD -0.5; TCGA PRAD -0.229; TCGA SARC -0.429; TCGA THCA -0.373; TCGA STAD -0.515 |
hsa-miR-29a-5p | MIER3 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.109; TCGA BRCA -0.067; TCGA HNSC -0.085; TCGA KIRP -0.105; TCGA LGG -0.069; TCGA LUAD -0.101; TCGA PRAD -0.147; TCGA SARC -0.126; TCGA THCA -0.068 |
hsa-miR-29a-5p | KCND2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; mirMAP | TCGA BLCA -0.277; TCGA BRCA -0.155; TCGA COAD -0.835; TCGA ESCA -0.565; TCGA HNSC -0.307; TCGA LUAD -0.184; TCGA LUSC -0.407; TCGA PAAD -0.678; TCGA PRAD -0.249; TCGA THCA -0.267 |
hsa-miR-29a-5p | TACC1 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget; mirMAP | TCGA BLCA -0.281; TCGA BRCA -0.089; TCGA COAD -0.204; TCGA HNSC -0.185; TCGA KIRP -0.145; TCGA LUAD -0.313; TCGA PAAD -0.268; TCGA PRAD -0.176; TCGA SARC -0.236; TCGA THCA -0.178; TCGA STAD -0.454 |
hsa-miR-29a-5p | ARL15 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.133; TCGA BRCA -0.115; TCGA CESC -0.228; TCGA COAD -0.209; TCGA ESCA -0.211; TCGA HNSC -0.201; TCGA KIRP -0.274; TCGA LIHC -0.112; TCGA LUAD -0.219; TCGA LUSC -0.097; TCGA PRAD -0.182; TCGA SARC -0.118; TCGA THCA -0.209; TCGA STAD -0.133 |
hsa-miR-29a-5p | SYNM | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.567; TCGA CESC -0.224; TCGA COAD -0.981; TCGA ESCA -0.927; TCGA KIRC -0.29; TCGA LIHC -0.358; TCGA LUAD -0.173; TCGA LUSC -0.167; TCGA PRAD -0.251; TCGA SARC -0.896; TCGA THCA -0.471; TCGA STAD -1.547 |
hsa-miR-29a-5p | SKIL | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA | MirTarget; miRNATAP | TCGA BLCA -0.163; TCGA CESC -0.273; TCGA COAD -0.138; TCGA HNSC -0.258; TCGA KIRP -0.29; TCGA LIHC -0.272; TCGA LUAD -0.197; TCGA LUSC -0.165; TCGA PRAD -0.211; TCGA THCA -0.228 |
hsa-miR-29a-5p | FOXN3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.29; TCGA BRCA -0.073; TCGA CESC -0.166; TCGA COAD -0.226; TCGA ESCA -0.288; TCGA HNSC -0.204; TCGA LUAD -0.17; TCGA PAAD -0.162; TCGA PRAD -0.075; TCGA SARC -0.333; TCGA THCA -0.153; TCGA STAD -0.319 |
hsa-miR-29a-5p | EPHA3 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.384; TCGA BRCA -0.191; TCGA COAD -0.615; TCGA ESCA -0.376; TCGA HNSC -0.35; TCGA KIRC -0.355; TCGA LIHC -0.358; TCGA LUAD -0.416; TCGA LUSC -0.248; TCGA PAAD -0.745; TCGA PRAD -0.122; TCGA THCA -0.371; TCGA STAD -0.627 |
hsa-miR-29a-5p | KIAA2022 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.615; TCGA BRCA -0.183; TCGA CESC -0.838; TCGA COAD -0.95; TCGA ESCA -0.981; TCGA HNSC -0.466; TCGA KIRP -0.608; TCGA PRAD -0.148; TCGA SARC -1.195; TCGA THCA -0.584; TCGA STAD -1.292; TCGA UCEC -0.487 |
hsa-miR-29a-5p | FAM168A | 13 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.1; TCGA CESC -0.298; TCGA COAD -0.247; TCGA HNSC -0.236; TCGA KIRP -0.403; TCGA LIHC -0.212; TCGA LUAD -0.153; TCGA LUSC -0.103; TCGA PAAD -0.238; TCGA PRAD -0.303; TCGA SARC -0.158; TCGA THCA -0.422; TCGA STAD -0.112 |
hsa-miR-29a-5p | ANKS1A | 10 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.253; TCGA ESCA -0.122; TCGA HNSC -0.122; TCGA KIRC -0.182; TCGA KIRP -0.159; TCGA LUAD -0.102; TCGA PRAD -0.051; TCGA SARC -0.136; TCGA THCA -0.192; TCGA STAD -0.228 |
hsa-miR-29a-5p | MEF2A | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.097; TCGA CESC -0.16; TCGA COAD -0.187; TCGA ESCA -0.164; TCGA HNSC -0.104; TCGA KIRC -0.076; TCGA LIHC -0.117; TCGA LUAD -0.089; TCGA PRAD -0.1; TCGA SARC -0.233; TCGA THCA -0.148; TCGA STAD -0.27 |
hsa-miR-29a-5p | ABCC9 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.26; TCGA BRCA -0.172; TCGA COAD -0.733; TCGA ESCA -0.418; TCGA HNSC -0.292; TCGA LUAD -0.173; TCGA PAAD -0.49; TCGA PRAD -0.249; TCGA SARC -0.385; TCGA THCA -0.357; TCGA STAD -0.79 |
hsa-miR-29a-5p | ADCY2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD | mirMAP | TCGA BLCA -0.493; TCGA BRCA -0.158; TCGA COAD -0.774; TCGA ESCA -1.078; TCGA HNSC -0.269; TCGA KIRC -0.39; TCGA LUAD -0.273; TCGA LUSC -0.413; TCGA SARC -1.068; TCGA STAD -1.051 |
hsa-miR-29a-5p | TNRC6C | 10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; SARC; STAD | mirMAP | TCGA BLCA -0.239; TCGA BRCA -0.11; TCGA HNSC -0.12; TCGA KIRC -0.099; TCGA LGG -0.051; TCGA LIHC -0.121; TCGA LUAD -0.083; TCGA LUSC -0.168; TCGA SARC -0.212; TCGA STAD -0.204 |
hsa-miR-29a-5p | NCOA1 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.225; TCGA CESC -0.152; TCGA COAD -0.141; TCGA ESCA -0.108; TCGA HNSC -0.231; TCGA KIRP -0.16; TCGA LIHC -0.106; TCGA LUAD -0.153; TCGA LUSC -0.082; TCGA PAAD -0.115; TCGA PRAD -0.146; TCGA THCA -0.142; TCGA STAD -0.121 |
hsa-miR-29a-5p | ARHGAP28 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.227; TCGA COAD -0.487; TCGA ESCA -0.456; TCGA HNSC -0.295; TCGA LUAD -0.328; TCGA PAAD -0.526; TCGA THCA -0.551; TCGA STAD -0.343; TCGA UCEC -0.171 |
hsa-miR-29a-5p | ZNF268 | 10 cancers: BLCA; ESCA; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.129; TCGA ESCA -0.174; TCGA KIRP -0.14; TCGA LGG -0.102; TCGA LIHC -0.133; TCGA LUAD -0.136; TCGA PRAD -0.1; TCGA SARC -0.185; TCGA THCA -0.209; TCGA STAD -0.228 |
hsa-miR-29a-5p | TTC28 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP; miRNATAP | TCGA BLCA -0.321; TCGA BRCA -0.163; TCGA COAD -0.412; TCGA ESCA -0.367; TCGA HNSC -0.419; TCGA KIRC -0.184; TCGA LGG -0.114; TCGA LIHC -0.134; TCGA LUAD -0.224; TCGA LUSC -0.208; TCGA PAAD -0.351; TCGA PRAD -0.145; TCGA SARC -0.235; TCGA THCA -0.175; TCGA STAD -0.523 |
hsa-miR-29a-5p | TNRC6B | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.124; TCGA CESC -0.102; TCGA ESCA -0.099; TCGA HNSC -0.192; TCGA KIRP -0.152; TCGA LGG -0.061; TCGA LIHC -0.074; TCGA LUAD -0.084; TCGA PRAD -0.142; TCGA SARC -0.121; TCGA THCA -0.164; TCGA STAD -0.089 |
hsa-miR-29a-5p | DICER1 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.137; TCGA CESC -0.163; TCGA COAD -0.064; TCGA HNSC -0.167; TCGA KIRP -0.157; TCGA LIHC -0.197; TCGA LUAD -0.102; TCGA PRAD -0.065; TCGA SARC -0.062; TCGA THCA -0.206; TCGA STAD -0.069; TCGA UCEC -0.081 |
hsa-miR-29a-5p | RASSF2 | 9 cancers: BLCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.316; TCGA COAD -0.584; TCGA HNSC -0.136; TCGA KIRC -0.352; TCGA LGG -0.322; TCGA LUAD -0.16; TCGA PAAD -0.292; TCGA THCA -0.236; TCGA STAD -0.288 |
hsa-miR-29a-5p | ANKRD12 | 11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.182; TCGA COAD -0.126; TCGA HNSC -0.075; TCGA KIRC -0.081; TCGA KIRP -0.145; TCGA LIHC -0.08; TCGA LUAD -0.077; TCGA PRAD -0.078; TCGA SARC -0.095; TCGA THCA -0.171; TCGA STAD -0.116 |
hsa-miR-29a-5p | ZC3H12B | 9 cancers: BLCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.394; TCGA HNSC -0.15; TCGA KIRP -0.283; TCGA LIHC -0.203; TCGA LUAD -0.168; TCGA LUSC -0.141; TCGA PRAD -0.202; TCGA SARC -0.465; TCGA STAD -0.293 |
hsa-miR-29a-5p | EEA1 | 10 cancers: BLCA; CESC; COAD; HNSC; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.168; TCGA CESC -0.125; TCGA COAD -0.079; TCGA HNSC -0.16; TCGA LIHC -0.159; TCGA LUAD -0.207; TCGA PRAD -0.169; TCGA SARC -0.089; TCGA THCA -0.19; TCGA STAD -0.114 |
hsa-miR-29a-5p | XYLT1 | 11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.191; TCGA COAD -0.204; TCGA HNSC -0.313; TCGA KIRC -0.179; TCGA KIRP -0.283; TCGA LGG -0.18; TCGA LUAD -0.193; TCGA LUSC -0.249; TCGA PAAD -0.331; TCGA PRAD -0.262; TCGA STAD -0.109 |
hsa-miR-29a-5p | BMF | 9 cancers: BLCA; BRCA; CESC; COAD; LGG; LIHC; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.164; TCGA BRCA -0.063; TCGA CESC -0.216; TCGA COAD -0.32; TCGA LGG -0.117; TCGA LIHC -0.257; TCGA PRAD -0.08; TCGA SARC -0.197; TCGA UCEC -0.137 |
hsa-miR-29a-5p | MTMR9 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.127; TCGA BRCA -0.051; TCGA CESC -0.116; TCGA COAD -0.154; TCGA HNSC -0.084; TCGA LIHC -0.097; TCGA LUAD -0.136; TCGA LUSC -0.12; TCGA SARC -0.176; TCGA THCA -0.11; TCGA STAD -0.213; TCGA UCEC -0.072 |
hsa-miR-29a-5p | KANK1 | 9 cancers: BLCA; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.275; TCGA ESCA -0.318; TCGA HNSC -0.164; TCGA LGG -0.162; TCGA LUAD -0.095; TCGA PAAD -0.258; TCGA PRAD -0.134; TCGA SARC -0.546; TCGA STAD -0.348 |
hsa-miR-29a-5p | MED13 | 9 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD | mirMAP | TCGA BLCA -0.11; TCGA CESC -0.116; TCGA HNSC -0.174; TCGA KIRP -0.221; TCGA LGG -0.094; TCGA LIHC -0.18; TCGA LUAD -0.133; TCGA LUSC -0.133; TCGA PRAD -0.131 |
hsa-miR-29a-5p | PHF12 | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; SARC; STAD | mirMAP | TCGA BLCA -0.109; TCGA BRCA -0.074; TCGA HNSC -0.062; TCGA KIRC -0.063; TCGA KIRP -0.082; TCGA LGG -0.08; TCGA LIHC -0.059; TCGA SARC -0.14; TCGA STAD -0.056 |
hsa-miR-29a-5p | SH3D19 | 10 cancers: BLCA; BRCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.164; TCGA BRCA -0.104; TCGA HNSC -0.189; TCGA LGG -0.086; TCGA LUAD -0.13; TCGA PAAD -0.415; TCGA PRAD -0.104; TCGA SARC -0.134; TCGA THCA -0.143; TCGA STAD -0.176 |
hsa-miR-29a-5p | RIC8B | 10 cancers: BLCA; CESC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.109; TCGA CESC -0.11; TCGA KIRP -0.114; TCGA LIHC -0.132; TCGA LUAD -0.143; TCGA LUSC -0.087; TCGA PAAD -0.15; TCGA SARC -0.136; TCGA THCA -0.167; TCGA STAD -0.099 |
hsa-miR-29a-5p | KCTD20 | 13 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.107; TCGA CESC -0.198; TCGA COAD -0.08; TCGA HNSC -0.223; TCGA KIRC -0.116; TCGA KIRP -0.195; TCGA LUAD -0.132; TCGA LUSC -0.104; TCGA PAAD -0.199; TCGA PRAD -0.17; TCGA SARC -0.13; TCGA THCA -0.263; TCGA STAD -0.194 |
hsa-miR-29a-5p | PHACTR2 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.154; TCGA HNSC -0.21; TCGA KIRC -0.126; TCGA KIRP -0.116; TCGA LUAD -0.276; TCGA PAAD -0.242; TCGA PRAD -0.121; TCGA THCA -0.216; TCGA STAD -0.145 |
hsa-miR-29a-5p | SEMA5A | 9 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.603; TCGA BRCA -0.216; TCGA HNSC -0.242; TCGA LGG -0.25; TCGA LIHC -0.33; TCGA LUAD -0.299; TCGA PRAD -0.338; TCGA SARC -0.452; TCGA THCA -0.172 |
hsa-miR-29a-5p | GHR | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP; miRNATAP | TCGA BLCA -0.399; TCGA BRCA -0.337; TCGA COAD -0.413; TCGA ESCA -0.974; TCGA HNSC -0.334; TCGA LIHC -0.364; TCGA LUAD -0.408; TCGA PAAD -0.293; TCGA PRAD -0.411; TCGA SARC -0.571; TCGA THCA -0.479; TCGA STAD -0.869 |
hsa-miR-29a-5p | PDE8B | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.282; TCGA BRCA -0.266; TCGA COAD -0.37; TCGA HNSC -0.114; TCGA LUAD -0.328; TCGA PAAD -0.386; TCGA PRAD -0.552; TCGA SARC -0.474; TCGA THCA -0.364; TCGA STAD -0.51 |
hsa-miR-29a-5p | CDH6 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.23; TCGA BRCA -0.159; TCGA COAD -0.345; TCGA HNSC -0.241; TCGA KIRC -0.384; TCGA LUAD -0.338; TCGA PAAD -0.566; TCGA PRAD -0.161; TCGA SARC -0.32; TCGA STAD -0.277 |
hsa-miR-29a-5p | PRKAR2A | 10 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.172; TCGA CESC -0.316; TCGA HNSC -0.346; TCGA KIRP -0.355; TCGA LUAD -0.144; TCGA LUSC -0.123; TCGA PRAD -0.297; TCGA SARC -0.229; TCGA THCA -0.552; TCGA STAD -0.088 |
hsa-miR-29a-5p | TPO | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.482; TCGA BRCA -0.498; TCGA COAD -0.836; TCGA ESCA -0.682; TCGA HNSC -0.27; TCGA LUSC -0.497; TCGA PAAD -0.619; TCGA PRAD -0.351; TCGA THCA -1.054; TCGA STAD -0.778 |
hsa-miR-29a-5p | EPHA4 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.254; TCGA CESC -0.421; TCGA COAD -0.751; TCGA ESCA -0.843; TCGA HNSC -0.324; TCGA KIRP -0.405; TCGA LIHC -0.212; TCGA LUSC -0.215; TCGA PAAD -0.353; TCGA SARC -0.365; TCGA STAD -0.51; TCGA UCEC -0.272 |
hsa-miR-29a-5p | FAM20B | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.066; TCGA CESC -0.127; TCGA ESCA -0.141; TCGA HNSC -0.106; TCGA KIRP -0.198; TCGA LUAD -0.104; TCGA SARC -0.145; TCGA THCA -0.07; TCGA STAD -0.19 |
hsa-miR-29a-5p | LEPR | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.14; TCGA BRCA -0.197; TCGA COAD -0.339; TCGA ESCA -0.282; TCGA HNSC -0.187; TCGA LUAD -0.382; TCGA PAAD -0.295; TCGA PRAD -0.238; TCGA THCA -0.143; TCGA STAD -0.488 |
hsa-miR-29a-5p | MTR | 10 cancers: BLCA; CESC; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.114; TCGA CESC -0.094; TCGA HNSC -0.119; TCGA KIRP -0.115; TCGA LUSC -0.099; TCGA PAAD -0.144; TCGA PRAD -0.066; TCGA SARC -0.183; TCGA THCA -0.116; TCGA STAD -0.198 |
hsa-miR-29a-5p | CNR1 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.574; TCGA COAD -1.022; TCGA ESCA -0.56; TCGA HNSC -0.281; TCGA KIRP -0.513; TCGA LUAD -0.19; TCGA PRAD -0.137; TCGA SARC -0.995; TCGA THCA -0.517; TCGA STAD -0.948 |
hsa-miR-29a-5p | FOXO3 | 13 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.122; TCGA CESC -0.125; TCGA HNSC -0.193; TCGA KIRC -0.117; TCGA KIRP -0.138; TCGA LGG -0.064; TCGA LIHC -0.083; TCGA LUAD -0.161; TCGA LUSC -0.093; TCGA PAAD -0.158; TCGA PRAD -0.112; TCGA SARC -0.088; TCGA STAD -0.153 |
hsa-miR-29a-5p | ACVR2A | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PAAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.284; TCGA BRCA -0.061; TCGA CESC -0.208; TCGA COAD -0.096; TCGA HNSC -0.174; TCGA KIRP -0.097; TCGA LIHC -0.068; TCGA LUAD -0.123; TCGA PAAD -0.111; TCGA STAD -0.136; TCGA UCEC -0.081 |
hsa-miR-29a-5p | PTGFR | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.219; TCGA COAD -0.833; TCGA ESCA -0.314; TCGA HNSC -0.218; TCGA KIRP -1.077; TCGA LGG -0.262; TCGA LIHC -0.696; TCGA LUAD -0.401; TCGA PAAD -0.657; TCGA THCA -0.419; TCGA STAD -0.567 |
hsa-miR-29a-5p | FAM63B | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.235; TCGA CESC -0.206; TCGA COAD -0.335; TCGA ESCA -0.138; TCGA HNSC -0.351; TCGA KIRP -0.479; TCGA LIHC -0.164; TCGA LUAD -0.217; TCGA LUSC -0.133; TCGA PRAD -0.255; TCGA SARC -0.339; TCGA THCA -0.454; TCGA STAD -0.201 |
hsa-miR-29a-5p | ARPP19 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.072; TCGA CESC -0.116; TCGA COAD -0.078; TCGA ESCA -0.087; TCGA HNSC -0.053; TCGA LUAD -0.111; TCGA PRAD -0.105; TCGA SARC -0.129; TCGA THCA -0.076; TCGA STAD -0.085; TCGA UCEC -0.065 |
hsa-miR-29a-5p | KIF1A | 11 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.524; TCGA COAD -0.963; TCGA ESCA -0.769; TCGA HNSC -0.489; TCGA LIHC -0.553; TCGA LUAD -0.569; TCGA LUSC -0.69; TCGA PRAD -0.166; TCGA SARC -1.069; TCGA THCA -0.762; TCGA STAD -1.27 |
hsa-miR-29a-5p | SYNE1 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.261; TCGA BRCA -0.101; TCGA COAD -0.72; TCGA HNSC -0.209; TCGA KIRP -0.243; TCGA LIHC -0.149; TCGA PAAD -0.232; TCGA PRAD -0.153; TCGA SARC -0.24; TCGA THCA -0.45; TCGA STAD -0.548 |
hsa-miR-29a-5p | IL6ST | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.312; TCGA CESC -0.281; TCGA COAD -0.507; TCGA HNSC -0.571; TCGA KIRP -0.631; TCGA LUAD -0.363; TCGA PRAD -0.44; TCGA SARC -0.33; TCGA THCA -0.709; TCGA STAD -0.299 |
hsa-miR-29a-5p | CLOCK | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.133; TCGA CESC -0.246; TCGA COAD -0.114; TCGA HNSC -0.242; TCGA KIRP -0.323; TCGA LIHC -0.222; TCGA PRAD -0.315; TCGA SARC -0.145; TCGA THCA -0.477; TCGA STAD -0.097 |
hsa-miR-29a-5p | CEP350 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.118; TCGA CESC -0.142; TCGA HNSC -0.172; TCGA KIRP -0.14; TCGA LIHC -0.146; TCGA LUAD -0.055; TCGA PRAD -0.141; TCGA SARC -0.104; TCGA THCA -0.129 |
hsa-miR-29a-5p | EDNRB | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.314; TCGA BRCA -0.138; TCGA COAD -0.463; TCGA HNSC -0.275; TCGA KIRC -0.511; TCGA LUAD -0.349; TCGA SARC -0.269; TCGA THCA -0.217; TCGA STAD -0.347 |
hsa-miR-29a-5p | STX17 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.052; TCGA CESC -0.056; TCGA HNSC -0.065; TCGA KIRP -0.125; TCGA LIHC -0.114; TCGA LUAD -0.078; TCGA SARC -0.141; TCGA THCA -0.088; TCGA STAD -0.098 |
hsa-miR-29a-5p | TSTD2 | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.087; TCGA CESC -0.187; TCGA HNSC -0.112; TCGA KIRP -0.164; TCGA LGG -0.072; TCGA LUAD -0.053; TCGA PRAD -0.165; TCGA SARC -0.126; TCGA THCA -0.169; TCGA STAD -0.236 |
hsa-miR-29a-5p | RAB30 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.118; TCGA BRCA -0.128; TCGA COAD -0.284; TCGA HNSC -0.213; TCGA KIRP -0.311; TCGA LUAD -0.161; TCGA PRAD -0.223; TCGA SARC -0.226; TCGA THCA -0.305; TCGA STAD -0.191 |
hsa-miR-29a-5p | PREPL | 10 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.181; TCGA CESC -0.105; TCGA HNSC -0.115; TCGA KIRP -0.091; TCGA LUAD -0.099; TCGA LUSC -0.076; TCGA PRAD -0.098; TCGA SARC -0.092; TCGA THCA -0.121; TCGA STAD -0.107 |
hsa-miR-29a-5p | FRAS1 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.196; TCGA CESC -0.426; TCGA COAD -0.49; TCGA HNSC -0.261; TCGA KIRP -0.532; TCGA LUAD -0.508; TCGA LUSC -0.376; TCGA PAAD -0.629; TCGA PRAD -0.303; TCGA THCA -0.451; TCGA STAD -0.324; TCGA UCEC -0.136 |
hsa-miR-29a-5p | TMTC3 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.102; TCGA CESC -0.2; TCGA COAD -0.134; TCGA ESCA -0.291; TCGA HNSC -0.188; TCGA KIRP -0.153; TCGA LIHC -0.11; TCGA LUAD -0.186; TCGA LUSC -0.107; TCGA PRAD -0.206; TCGA THCA -0.133; TCGA STAD -0.113; TCGA UCEC -0.099 |
hsa-miR-29a-5p | PELI2 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.315; TCGA BRCA -0.17; TCGA CESC -0.212; TCGA COAD -0.337; TCGA HNSC -0.304; TCGA LGG -0.079; TCGA LUAD -0.256; TCGA PAAD -0.325; TCGA PRAD -0.109; TCGA SARC -0.357; TCGA THCA -0.19; TCGA STAD -0.219 |
hsa-miR-29a-5p | NCOA2 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.354; TCGA CESC -0.415; TCGA COAD -0.198; TCGA HNSC -0.451; TCGA KIRP -0.48; TCGA LUAD -0.16; TCGA PRAD -0.331; TCGA SARC -0.394; TCGA THCA -0.475 |
hsa-miR-29a-5p | GNAL | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.475; TCGA BRCA -0.142; TCGA CESC -0.467; TCGA COAD -0.557; TCGA ESCA -0.602; TCGA HNSC -0.205; TCGA LUAD -0.255; TCGA PRAD -0.337; TCGA SARC -0.87; TCGA THCA -0.513; TCGA STAD -0.765 |
hsa-miR-29a-5p | RPRD1A | 9 cancers: BLCA; CESC; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.143; TCGA CESC -0.099; TCGA HNSC -0.092; TCGA LIHC -0.092; TCGA LUAD -0.065; TCGA LUSC -0.104; TCGA PRAD -0.116; TCGA SARC -0.209; TCGA STAD -0.119 |
hsa-miR-29a-5p | MAPK4 | 9 cancers: BLCA; COAD; ESCA; KIRP; LIHC; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.662; TCGA COAD -0.958; TCGA ESCA -0.765; TCGA KIRP -0.727; TCGA LIHC -0.75; TCGA LUAD -0.507; TCGA SARC -1.699; TCGA THCA -0.961; TCGA STAD -1.736 |
hsa-miR-29a-5p | NFIC | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.124; TCGA BRCA -0.074; TCGA CESC -0.187; TCGA COAD -0.242; TCGA ESCA -0.272; TCGA HNSC -0.329; TCGA KIRP -0.304; TCGA PAAD -0.219; TCGA PRAD -0.216; TCGA SARC -0.281; TCGA THCA -0.382; TCGA STAD -0.227 |
hsa-miR-29a-5p | HUNK | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.582; TCGA BRCA -0.19; TCGA CESC -0.348; TCGA ESCA -0.405; TCGA HNSC -0.264; TCGA LGG -0.182; TCGA LIHC -0.665; TCGA LUAD -0.185; TCGA LUSC -0.327; TCGA PAAD -0.466; TCGA PRAD -0.219; TCGA SARC -0.893; TCGA THCA -0.424; TCGA STAD -0.186 |
hsa-miR-29a-5p | SYPL2 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.333; TCGA BRCA -0.202; TCGA COAD -0.622; TCGA ESCA -0.28; TCGA LUAD -0.269; TCGA PAAD -0.415; TCGA PRAD -0.112; TCGA THCA -0.242; TCGA STAD -0.818 |
hsa-miR-29a-5p | CTTNBP2NL | 10 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.11; TCGA CESC -0.155; TCGA COAD -0.064; TCGA HNSC -0.146; TCGA LUAD -0.1; TCGA LUSC -0.095; TCGA PAAD -0.134; TCGA PRAD -0.158; TCGA THCA -0.12; TCGA STAD -0.085 |
hsa-miR-29a-5p | RGS5 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LIHC; LUAD; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.535; TCGA BRCA -0.207; TCGA COAD -0.551; TCGA HNSC -0.322; TCGA KIRC -0.721; TCGA LIHC -0.198; TCGA LUAD -0.256; TCGA PAAD -0.275; TCGA SARC -0.387; TCGA THCA -0.132; TCGA STAD -0.615 |
hsa-miR-29a-5p | GATAD2B | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.072; TCGA CESC -0.092; TCGA COAD -0.053; TCGA HNSC -0.129; TCGA KIRP -0.122; TCGA LGG -0.069; TCGA LIHC -0.084; TCGA LUSC -0.074; TCGA PRAD -0.073; TCGA SARC -0.134; TCGA STAD -0.089 |
hsa-miR-29a-5p | SPOPL | 11 cancers: BLCA; BRCA; CESC; COAD; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.14; TCGA BRCA -0.102; TCGA CESC -0.081; TCGA COAD -0.077; TCGA KIRP -0.15; TCGA LIHC -0.149; TCGA LUAD -0.097; TCGA PRAD -0.222; TCGA SARC -0.113; TCGA THCA -0.122; TCGA STAD -0.063 |
hsa-miR-29a-5p | ITGA9 | 10 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.245; TCGA COAD -0.436; TCGA ESCA -0.371; TCGA HNSC -0.333; TCGA LIHC -0.222; TCGA LUAD -0.205; TCGA PAAD -0.486; TCGA PRAD -0.265; TCGA SARC -0.226; TCGA STAD -0.663 |
hsa-miR-29a-5p | SETD7 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.074; TCGA BRCA -0.06; TCGA CESC -0.103; TCGA COAD -0.116; TCGA ESCA -0.116; TCGA HNSC -0.178; TCGA KIRC -0.119; TCGA KIRP -0.177; TCGA LGG -0.068; TCGA LUAD -0.066; TCGA PAAD -0.257; TCGA PRAD -0.123; TCGA THCA -0.253; TCGA STAD -0.236 |
hsa-miR-29a-5p | TSLP | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD | mirMAP | TCGA BLCA -0.208; TCGA BRCA -0.163; TCGA COAD -0.413; TCGA ESCA -0.487; TCGA HNSC -0.155; TCGA KIRP -0.552; TCGA LUAD -0.261; TCGA LUSC -0.318; TCGA PAAD -0.353; TCGA STAD -0.819 |
hsa-miR-29a-5p | DIAPH2 | 10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.096; TCGA HNSC -0.18; TCGA KIRC -0.143; TCGA KIRP -0.138; TCGA LGG -0.152; TCGA LUAD -0.117; TCGA PAAD -0.155; TCGA PRAD -0.183; TCGA SARC -0.253; TCGA STAD -0.096 |
hsa-miR-29a-5p | NTRK2 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.414; TCGA CESC -0.44; TCGA COAD -0.406; TCGA ESCA -1.119; TCGA HNSC -0.622; TCGA LIHC -0.496; TCGA LUAD -0.346; TCGA PAAD -0.507; TCGA PRAD -0.248; TCGA SARC -0.896; TCGA THCA -0.104; TCGA STAD -0.767; TCGA UCEC -0.273 |
hsa-miR-29a-5p | ZEB1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.223; TCGA BRCA -0.212; TCGA COAD -0.666; TCGA ESCA -0.23; TCGA HNSC -0.151; TCGA KIRC -0.274; TCGA LGG -0.2; TCGA LUAD -0.197; TCGA PAAD -0.304; TCGA PRAD -0.108; TCGA SARC -0.109; TCGA THCA -0.281; TCGA STAD -0.598 |
hsa-miR-29a-5p | NCAM1 | 9 cancers: BLCA; COAD; ESCA; LGG; LUAD; LUSC; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.483; TCGA COAD -0.789; TCGA ESCA -0.844; TCGA LGG -0.113; TCGA LUAD -0.41; TCGA LUSC -0.256; TCGA SARC -0.641; TCGA THCA -0.672; TCGA STAD -1.035 |
hsa-miR-29a-5p | MPP7 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.45; TCGA BRCA -0.16; TCGA CESC -0.22; TCGA ESCA -0.267; TCGA HNSC -0.278; TCGA KIRP -0.174; TCGA PAAD -0.254; TCGA PRAD -0.209; TCGA SARC -0.757; TCGA STAD -0.447 |
hsa-miR-29a-5p | DIXDC1 | 11 cancers: BLCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.208; TCGA COAD -0.428; TCGA HNSC -0.138; TCGA KIRC -0.101; TCGA LUAD -0.23; TCGA LUSC -0.18; TCGA PAAD -0.325; TCGA PRAD -0.079; TCGA SARC -0.449; TCGA THCA -0.233; TCGA STAD -0.679 |
hsa-miR-29a-5p | FREM2 | 10 cancers: BLCA; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.993; TCGA ESCA -0.636; TCGA HNSC -0.547; TCGA LUAD -0.462; TCGA LUSC -0.517; TCGA PAAD -0.945; TCGA PRAD -0.17; TCGA THCA -0.425; TCGA STAD -0.977; TCGA UCEC -0.315 |
hsa-miR-29a-5p | MGAT5 | 9 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.18; TCGA CESC -0.397; TCGA HNSC -0.411; TCGA KIRP -0.592; TCGA LUAD -0.167; TCGA LUSC -0.213; TCGA PRAD -0.477; TCGA SARC -0.261; TCGA THCA -0.494 |
hsa-miR-29a-5p | ZNF776 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.162; TCGA HNSC -0.067; TCGA KIRC -0.075; TCGA KIRP -0.207; TCGA LIHC -0.121; TCGA LUAD -0.084; TCGA PRAD -0.072; TCGA SARC -0.119; TCGA THCA -0.069 |
hsa-miR-29a-5p | PDE1C | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.68; TCGA COAD -0.513; TCGA ESCA -0.415; TCGA HNSC -0.342; TCGA KIRP -0.672; TCGA LUAD -0.296; TCGA PAAD -0.405; TCGA SARC -0.648; TCGA STAD -0.682 |
hsa-miR-29a-5p | GABPA | 10 cancers: BLCA; CESC; COAD; KIRP; LGG; LIHC; LUAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.123; TCGA CESC -0.117; TCGA COAD -0.077; TCGA KIRP -0.209; TCGA LGG -0.094; TCGA LIHC -0.144; TCGA LUAD -0.12; TCGA PRAD -0.121; TCGA THCA -0.112; TCGA STAD -0.076 |
hsa-miR-29a-5p | ADAMTS5 | 12 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.169; TCGA COAD -0.327; TCGA HNSC -0.276; TCGA KIRC -0.254; TCGA KIRP -0.698; TCGA LGG -0.36; TCGA LIHC -0.177; TCGA LUAD -0.183; TCGA LUSC -0.291; TCGA PRAD -0.164; TCGA THCA -0.452; TCGA STAD -0.212 |
hsa-miR-29a-5p | ERG | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.113; TCGA BRCA -0.213; TCGA COAD -0.524; TCGA HNSC -0.119; TCGA KIRC -0.337; TCGA KIRP -0.26; TCGA LIHC -0.141; TCGA LUAD -0.262; TCGA PAAD -0.375; TCGA PRAD -0.498; TCGA SARC -0.143; TCGA THCA -0.202; TCGA STAD -0.297 |
hsa-miR-29a-5p | TSPAN18 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.256; TCGA COAD -0.449; TCGA ESCA -0.437; TCGA HNSC -0.281; TCGA KIRC -0.413; TCGA LIHC -0.169; TCGA LUAD -0.272; TCGA PRAD -0.143; TCGA SARC -0.404; TCGA THCA -0.316; TCGA STAD -0.548 |
hsa-miR-29a-5p | ZSCAN12 | 9 cancers: BLCA; KIRC; KIRP; LGG; LIHC; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.164; TCGA KIRC -0.08; TCGA KIRP -0.204; TCGA LGG -0.139; TCGA LIHC -0.189; TCGA LUAD -0.139; TCGA SARC -0.151; TCGA THCA -0.116; TCGA STAD -0.314 |
hsa-miR-29a-5p | TAOK1 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.272; TCGA CESC -0.288; TCGA COAD -0.225; TCGA HNSC -0.484; TCGA KIRP -0.391; TCGA LIHC -0.285; TCGA LUAD -0.216; TCGA LUSC -0.158; TCGA PRAD -0.397; TCGA SARC -0.233; TCGA THCA -0.599; TCGA STAD -0.104 |
hsa-miR-29a-5p | NFIA | 10 cancers: BLCA; BRCA; HNSC; KIRC; LUAD; PAAD; SARC; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.154; TCGA BRCA -0.084; TCGA HNSC -0.085; TCGA KIRC -0.194; TCGA LUAD -0.194; TCGA PAAD -0.297; TCGA SARC -0.347; TCGA THCA -0.072; TCGA STAD -0.37; TCGA UCEC -0.102 |
hsa-miR-29a-5p | FAM102B | 9 cancers: BLCA; CESC; COAD; HNSC; LUAD; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.191; TCGA CESC -0.223; TCGA COAD -0.077; TCGA HNSC -0.13; TCGA LUAD -0.246; TCGA PAAD -0.259; TCGA PRAD -0.112; TCGA SARC -0.197; TCGA UCEC -0.144 |
hsa-miR-29a-5p | WDR26 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PRAD; SARC; STAD | mirMAP; miRNATAP | TCGA BLCA -0.084; TCGA CESC -0.09; TCGA COAD -0.063; TCGA ESCA -0.132; TCGA HNSC -0.09; TCGA KIRP -0.115; TCGA PRAD -0.092; TCGA SARC -0.073; TCGA STAD -0.139 |
hsa-miR-29a-5p | GNPDA2 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRP; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.074; TCGA BRCA -0.062; TCGA CESC -0.107; TCGA COAD -0.074; TCGA KIRP -0.111; TCGA PRAD -0.074; TCGA SARC -0.094; TCGA THCA -0.066; TCGA STAD -0.228 |
hsa-miR-29a-5p | GRIK3 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; STAD | mirMAP | TCGA BLCA -0.576; TCGA BRCA -0.431; TCGA COAD -0.587; TCGA ESCA -0.954; TCGA KIRC -1.488; TCGA LUAD -0.294; TCGA LUSC -0.303; TCGA PAAD -0.476; TCGA STAD -1.133 |
hsa-miR-29a-5p | UBXN7 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.09; TCGA CESC -0.284; TCGA COAD -0.137; TCGA HNSC -0.321; TCGA KIRP -0.278; TCGA LIHC -0.17; TCGA LUAD -0.158; TCGA PRAD -0.241; TCGA SARC -0.119; TCGA THCA -0.267 |
hsa-miR-29a-5p | TMEM184C | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.066; TCGA CESC -0.074; TCGA COAD -0.05; TCGA HNSC -0.135; TCGA KIRP -0.145; TCGA LUAD -0.065; TCGA PAAD -0.112; TCGA PRAD -0.169; TCGA THCA -0.188 |
hsa-miR-29a-5p | ZNF704 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.488; TCGA BRCA -0.095; TCGA CESC -0.334; TCGA COAD -0.186; TCGA HNSC -0.409; TCGA KIRP -0.406; TCGA LGG -0.126; TCGA LUAD -0.294; TCGA LUSC -0.23; TCGA PAAD -0.579; TCGA PRAD -0.254; TCGA SARC -0.577; TCGA THCA -0.463; TCGA STAD -0.511 |
hsa-miR-29a-5p | DIRAS2 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.716; TCGA ESCA -0.787; TCGA HNSC -0.492; TCGA KIRC -0.631; TCGA LUAD -0.263; TCGA PRAD -0.304; TCGA THCA -0.568; TCGA STAD -0.682; TCGA UCEC -0.203 |
hsa-miR-29a-5p | PCDH19 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.658; TCGA BRCA -0.345; TCGA COAD -0.466; TCGA ESCA -1.065; TCGA HNSC -0.618; TCGA KIRP -0.247; TCGA LUAD -0.296; TCGA LUSC -0.589; TCGA PAAD -0.704; TCGA SARC -0.477; TCGA THCA -0.268; TCGA STAD -0.639 |
hsa-miR-29a-5p | ATP7A | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.249; TCGA BRCA -0.074; TCGA CESC -0.179; TCGA COAD -0.09; TCGA HNSC -0.263; TCGA KIRP -0.201; TCGA LUAD -0.088; TCGA LUSC -0.076; TCGA PRAD -0.101; TCGA SARC -0.088; TCGA THCA -0.154; TCGA STAD -0.13; TCGA UCEC -0.08 |
hsa-miR-29a-5p | TAF3 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.064; TCGA CESC -0.109; TCGA HNSC -0.085; TCGA KIRP -0.254; TCGA LIHC -0.099; TCGA LUAD -0.131; TCGA PRAD -0.055; TCGA SARC -0.066; TCGA THCA -0.139 |
hsa-miR-29a-5p | NSD1 | 10 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.057; TCGA CESC -0.152; TCGA HNSC -0.149; TCGA KIRP -0.085; TCGA LIHC -0.116; TCGA LUAD -0.08; TCGA LUSC -0.081; TCGA PRAD -0.141; TCGA SARC -0.082; TCGA THCA -0.157 |
hsa-miR-29a-5p | RNF169 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.148; TCGA CESC -0.208; TCGA COAD -0.076; TCGA HNSC -0.221; TCGA KIRP -0.272; TCGA LGG -0.07; TCGA LIHC -0.196; TCGA LUAD -0.109; TCGA PRAD -0.199; TCGA SARC -0.148; TCGA THCA -0.238 |
hsa-miR-29a-5p | CDKN2AIP | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.09; TCGA CESC -0.115; TCGA HNSC -0.114; TCGA KIRP -0.245; TCGA LGG -0.058; TCGA LUAD -0.065; TCGA PRAD -0.113; TCGA SARC -0.163; TCGA THCA -0.072; TCGA UCEC -0.071 |
hsa-miR-29a-5p | FEM1B | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.13; TCGA CESC -0.161; TCGA COAD -0.129; TCGA ESCA -0.208; TCGA HNSC -0.082; TCGA KIRP -0.107; TCGA LIHC -0.155; TCGA LUAD -0.162; TCGA PAAD -0.137; TCGA PRAD -0.159; TCGA SARC -0.29; TCGA THCA -0.098; TCGA STAD -0.227 |
hsa-miR-29a-5p | AR | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.902; TCGA BRCA -0.591; TCGA COAD -0.917; TCGA ESCA -0.46; TCGA HNSC -0.744; TCGA LUAD -0.388; TCGA LUSC -0.387; TCGA PAAD -0.724; TCGA PRAD -0.282; TCGA SARC -0.832; TCGA THCA -0.836; TCGA STAD -0.916 |
hsa-miR-29a-5p | TOR1AIP2 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.099; TCGA CESC -0.195; TCGA COAD -0.093; TCGA HNSC -0.294; TCGA KIRP -0.368; TCGA LUAD -0.102; TCGA LUSC -0.1; TCGA PRAD -0.228; TCGA SARC -0.127; TCGA THCA -0.214 |
hsa-miR-29a-5p | SIK2 | 9 cancers: BLCA; COAD; HNSC; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.065; TCGA COAD -0.06; TCGA HNSC -0.137; TCGA LIHC -0.184; TCGA LUAD -0.137; TCGA PRAD -0.082; TCGA SARC -0.106; TCGA THCA -0.162; TCGA STAD -0.151 |
hsa-miR-29a-5p | SGCD | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.221; TCGA BRCA -0.255; TCGA COAD -0.811; TCGA ESCA -0.658; TCGA HNSC -0.343; TCGA LUAD -0.264; TCGA LUSC -0.318; TCGA PAAD -0.474; TCGA SARC -0.288; TCGA THCA -0.754; TCGA STAD -0.659; TCGA UCEC -0.373 |
hsa-miR-29a-5p | AKAP13 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; PAAD; PRAD | mirMAP | TCGA BLCA -0.099; TCGA CESC -0.183; TCGA COAD -0.244; TCGA HNSC -0.211; TCGA KIRC -0.164; TCGA LIHC -0.115; TCGA LUAD -0.11; TCGA PAAD -0.263; TCGA PRAD -0.159 |
hsa-miR-29a-5p | KCND3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.447; TCGA BRCA -0.248; TCGA CESC -0.448; TCGA COAD -0.996; TCGA ESCA -0.666; TCGA HNSC -0.324; TCGA KIRP -0.578; TCGA LUAD -0.299; TCGA LUSC -0.234; TCGA PRAD -0.276; TCGA SARC -1.022; TCGA STAD -0.454 |
hsa-miR-29a-5p | PDE7B | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.349; TCGA BRCA -0.196; TCGA COAD -0.58; TCGA ESCA -0.312; TCGA HNSC -0.167; TCGA KIRC -0.154; TCGA KIRP -0.36; TCGA LUAD -0.299; TCGA SARC -0.199; TCGA THCA -0.266; TCGA STAD -0.661 |
hsa-miR-29a-5p | KSR2 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.796; TCGA BRCA -0.15; TCGA CESC -0.392; TCGA COAD -0.227; TCGA HNSC -0.45; TCGA KIRP -0.439; TCGA LUAD -0.185; TCGA PRAD -0.242; TCGA SARC -0.356; TCGA THCA -0.147 |
hsa-miR-29a-5p | BCL2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.214; TCGA BRCA -0.159; TCGA COAD -0.344; TCGA ESCA -0.285; TCGA HNSC -0.155; TCGA KIRC -0.259; TCGA LUAD -0.237; TCGA LUSC -0.182; TCGA PAAD -0.251; TCGA PRAD -0.12; TCGA SARC -0.199; TCGA THCA -0.44; TCGA STAD -0.309 |
hsa-miR-29a-5p | SYNPO2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.689; TCGA BRCA -0.248; TCGA COAD -1.11; TCGA ESCA -0.944; TCGA HNSC -0.261; TCGA LIHC -0.179; TCGA LUAD -0.431; TCGA LUSC -0.286; TCGA PAAD -0.534; TCGA PRAD -0.256; TCGA SARC -1.062; TCGA THCA -0.341; TCGA STAD -1.356 |
hsa-miR-29a-5p | STOX2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.48; TCGA CESC -0.371; TCGA COAD -0.559; TCGA ESCA -0.838; TCGA HNSC -0.531; TCGA LUAD -0.218; TCGA PRAD -0.447; TCGA SARC -0.903; TCGA THCA -0.531; TCGA STAD -0.667 |
hsa-miR-29a-5p | SH3PXD2B | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.077; TCGA CESC -0.189; TCGA COAD -0.197; TCGA ESCA -0.362; TCGA HNSC -0.205; TCGA KIRC -0.172; TCGA LUSC -0.134; TCGA PAAD -0.324; TCGA PRAD -0.168; TCGA THCA -0.099; TCGA STAD -0.207 |
hsa-miR-29a-5p | MEX3C | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PRAD | mirMAP | TCGA BLCA -0.052; TCGA CESC -0.103; TCGA COAD -0.074; TCGA HNSC -0.086; TCGA KIRP -0.152; TCGA LGG -0.064; TCGA LUAD -0.079; TCGA LUSC -0.095; TCGA PRAD -0.087 |
hsa-miR-29a-5p | CHD9 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.127; TCGA CESC -0.212; TCGA COAD -0.197; TCGA ESCA -0.192; TCGA HNSC -0.16; TCGA KIRP -0.126; TCGA LGG -0.127; TCGA LUAD -0.079; TCGA PRAD -0.152; TCGA SARC -0.118; TCGA THCA -0.102; TCGA STAD -0.152 |
hsa-miR-29a-5p | SNX18 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.075; TCGA CESC -0.146; TCGA COAD -0.267; TCGA ESCA -0.258; TCGA HNSC -0.118; TCGA KIRP -0.247; TCGA LGG -0.071; TCGA LIHC -0.072; TCGA LUAD -0.073; TCGA PAAD -0.211; TCGA PRAD -0.097; TCGA SARC -0.154; TCGA THCA -0.122; TCGA STAD -0.173 |
hsa-miR-29a-5p | TSPYL5 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.341; TCGA COAD -0.645; TCGA ESCA -0.527; TCGA HNSC -0.243; TCGA KIRP -0.317; TCGA LUAD -0.138; TCGA PRAD -0.158; TCGA SARC -0.246; TCGA THCA -0.23; TCGA STAD -0.592 |
hsa-miR-29a-5p | AMIGO1 | 9 cancers: BLCA; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.225; TCGA HNSC -0.305; TCGA KIRP -0.204; TCGA LUAD -0.166; TCGA PAAD -0.249; TCGA PRAD -0.11; TCGA SARC -0.182; TCGA THCA -0.212; TCGA STAD -0.526 |
hsa-miR-29a-5p | CACNB4 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.574; TCGA BRCA -0.125; TCGA COAD -0.501; TCGA ESCA -0.335; TCGA KIRP -0.276; TCGA LUAD -0.273; TCGA PRAD -0.204; TCGA SARC -0.302; TCGA THCA -0.423; TCGA STAD -0.464 |
hsa-miR-29a-5p | TSHZ2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | mirMAP; miRNATAP | TCGA BLCA -0.309; TCGA BRCA -0.146; TCGA CESC -0.41; TCGA COAD -0.862; TCGA ESCA -0.312; TCGA HNSC -0.446; TCGA KIRP -0.541; TCGA LUAD -0.278; TCGA PAAD -0.506; TCGA PRAD -0.241; TCGA THCA -0.507; TCGA STAD -0.442 |
hsa-miR-29a-5p | PLCXD3 | 10 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.452; TCGA BRCA -0.467; TCGA COAD -1.023; TCGA ESCA -0.577; TCGA LIHC -0.343; TCGA LUAD -0.391; TCGA PRAD -0.145; TCGA SARC -0.416; TCGA THCA -0.275; TCGA STAD -1.21 |
hsa-miR-29a-5p | ST6GALNAC3 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.247; TCGA BRCA -0.118; TCGA COAD -0.28; TCGA HNSC -0.174; TCGA KIRP -0.334; TCGA LUAD -0.367; TCGA PAAD -0.244; TCGA SARC -0.212; TCGA THCA -0.191; TCGA STAD -0.427 |
hsa-miR-29a-5p | ZNF445 | 9 cancers: BLCA; HNSC; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.15; TCGA HNSC -0.081; TCGA LGG -0.091; TCGA LIHC -0.135; TCGA LUSC -0.082; TCGA PRAD -0.051; TCGA SARC -0.192; TCGA THCA -0.116; TCGA STAD -0.115 |
hsa-miR-29a-5p | PBX1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.456; TCGA BRCA -0.118; TCGA CESC -0.25; TCGA COAD -0.375; TCGA ESCA -0.378; TCGA HNSC -0.476; TCGA KIRP -0.408; TCGA LUAD -0.362; TCGA LUSC -0.29; TCGA PAAD -0.308; TCGA PRAD -0.186; TCGA SARC -0.682; TCGA STAD -0.618 |
hsa-miR-29a-5p | PTCH1 | 10 cancers: BLCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.169; TCGA HNSC -0.191; TCGA KIRP -0.283; TCGA LGG -0.152; TCGA LUAD -0.205; TCGA LUSC -0.201; TCGA PAAD -0.268; TCGA PRAD -0.15; TCGA THCA -0.097; TCGA STAD -0.207 |
hsa-miR-29a-5p | RGS7BP | 10 cancers: BLCA; COAD; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; STAD | mirMAP; miRNATAP | TCGA BLCA -0.737; TCGA COAD -0.803; TCGA HNSC -0.461; TCGA KIRP -0.49; TCGA LIHC -0.43; TCGA LUAD -0.456; TCGA PAAD -0.42; TCGA PRAD -0.34; TCGA SARC -0.856; TCGA STAD -0.738 |
hsa-miR-29a-5p | SESTD1 | 11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.285; TCGA COAD -0.168; TCGA HNSC -0.14; TCGA KIRC -0.118; TCGA KIRP -0.163; TCGA LUAD -0.17; TCGA PRAD -0.117; TCGA SARC -0.288; TCGA THCA -0.117; TCGA STAD -0.248; TCGA UCEC -0.159 |
hsa-miR-29a-5p | ZNF286A | 12 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.077; TCGA CESC -0.082; TCGA COAD -0.07; TCGA HNSC -0.061; TCGA KIRC -0.064; TCGA KIRP -0.222; TCGA LGG -0.14; TCGA LUAD -0.142; TCGA PRAD -0.055; TCGA SARC -0.153; TCGA THCA -0.088; TCGA UCEC -0.064 |
hsa-miR-29a-5p | JAKMIP3 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.407; TCGA BRCA -0.185; TCGA CESC -0.343; TCGA COAD -0.344; TCGA ESCA -0.69; TCGA HNSC -0.311; TCGA SARC -0.256; TCGA THCA -0.159; TCGA STAD -0.4 |
hsa-miR-29a-5p | RALGAPA2 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.448; TCGA CESC -0.437; TCGA HNSC -0.392; TCGA KIRP -0.39; TCGA LIHC -0.346; TCGA LUAD -0.214; TCGA PRAD -0.356; TCGA SARC -0.24; TCGA THCA -0.475 |
hsa-miR-29a-5p | PTPRT | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; SARC; STAD | mirMAP | TCGA BLCA -0.416; TCGA BRCA -0.589; TCGA COAD -0.594; TCGA ESCA -0.575; TCGA HNSC -0.346; TCGA LIHC -0.372; TCGA LUAD -0.378; TCGA SARC -0.763; TCGA STAD -0.615 |
hsa-miR-29a-5p | LCOR | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.365; TCGA CESC -0.281; TCGA COAD -0.133; TCGA HNSC -0.389; TCGA KIRP -0.404; TCGA LIHC -0.339; TCGA LUAD -0.202; TCGA PRAD -0.248; TCGA SARC -0.163; TCGA THCA -0.434 |
hsa-miR-29a-5p | NHLRC2 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.137; TCGA CESC -0.211; TCGA COAD -0.111; TCGA HNSC -0.21; TCGA KIRP -0.322; TCGA LIHC -0.184; TCGA LUAD -0.154; TCGA PRAD -0.282; TCGA THCA -0.422; TCGA STAD -0.095 |
hsa-miR-29a-5p | KPNA5 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.185; TCGA CESC -0.266; TCGA COAD -0.118; TCGA HNSC -0.082; TCGA KIRP -0.219; TCGA LIHC -0.167; TCGA LUAD -0.14; TCGA LUSC -0.131; TCGA PRAD -0.239; TCGA SARC -0.156; TCGA THCA -0.296; TCGA STAD -0.27 |
hsa-miR-29a-5p | KIAA1671 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.095; TCGA CESC -0.137; TCGA ESCA -0.171; TCGA HNSC -0.261; TCGA KIRC -0.093; TCGA LIHC -0.144; TCGA LUAD -0.155; TCGA PRAD -0.123; TCGA SARC -0.213; TCGA THCA -0.229 |
hsa-miR-29a-5p | PGAP1 | 10 cancers: BLCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.304; TCGA HNSC -0.131; TCGA KIRP -0.232; TCGA LGG -0.194; TCGA LUAD -0.188; TCGA LUSC -0.17; TCGA PRAD -0.228; TCGA SARC -0.34; TCGA THCA -0.151; TCGA STAD -0.164 |
hsa-miR-29a-5p | TRIM33 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.178; TCGA CESC -0.088; TCGA HNSC -0.085; TCGA KIRP -0.107; TCGA LIHC -0.107; TCGA LUAD -0.075; TCGA PRAD -0.152; TCGA SARC -0.115; TCGA UCEC -0.054 |
hsa-miR-29a-5p | ZNF677 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.228; TCGA COAD -0.599; TCGA ESCA -0.316; TCGA HNSC -0.185; TCGA KIRP -0.534; TCGA LUAD -0.139; TCGA PAAD -0.316; TCGA SARC -0.282; TCGA THCA -0.101; TCGA STAD -0.672 |
hsa-miR-29a-5p | RYR2 | 9 cancers: BLCA; COAD; ESCA; KIRP; LUAD; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.529; TCGA COAD -0.601; TCGA ESCA -0.678; TCGA KIRP -0.437; TCGA LUAD -0.163; TCGA PAAD -0.54; TCGA SARC -0.969; TCGA THCA -0.846; TCGA STAD -0.794 |
hsa-miR-29a-5p | FAM19A2 | 9 cancers: BLCA; COAD; ESCA; KIRP; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.245; TCGA COAD -0.245; TCGA ESCA -0.346; TCGA KIRP -0.158; TCGA LUAD -0.267; TCGA PAAD -0.356; TCGA PRAD -0.159; TCGA SARC -0.344; TCGA STAD -0.277 |
hsa-miR-29a-5p | RBM20 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.376; TCGA BRCA -0.187; TCGA CESC -0.288; TCGA COAD -0.466; TCGA ESCA -0.626; TCGA LIHC -0.257; TCGA PAAD -0.419; TCGA SARC -0.546; TCGA STAD -0.961 |
hsa-miR-29a-5p | BMPR2 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.148; TCGA CESC -0.081; TCGA COAD -0.257; TCGA HNSC -0.179; TCGA KIRP -0.214; TCGA LIHC -0.148; TCGA LUAD -0.214; TCGA PAAD -0.139; TCGA PRAD -0.168; TCGA SARC -0.122; TCGA THCA -0.148; TCGA STAD -0.18 |
hsa-miR-29a-5p | MBD5 | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.182; TCGA COAD -0.093; TCGA HNSC -0.081; TCGA KIRP -0.163; TCGA LUAD -0.063; TCGA LUSC -0.133; TCGA PRAD -0.142; TCGA SARC -0.249; TCGA THCA -0.137; TCGA STAD -0.23 |
hsa-miR-29a-5p | TRIM13 | 10 cancers: BLCA; CESC; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.142; TCGA CESC -0.097; TCGA HNSC -0.073; TCGA KIRC -0.124; TCGA LGG -0.056; TCGA LUAD -0.097; TCGA PAAD -0.087; TCGA PRAD -0.071; TCGA STAD -0.061; TCGA UCEC -0.079 |
hsa-miR-29a-5p | ITSN1 | 9 cancers: BLCA; BRCA; COAD; LIHC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.104; TCGA BRCA -0.085; TCGA COAD -0.149; TCGA LIHC -0.101; TCGA LUAD -0.117; TCGA PAAD -0.215; TCGA PRAD -0.068; TCGA THCA -0.093; TCGA STAD -0.164 |
hsa-miR-29a-5p | DOK6 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.496; TCGA BRCA -0.245; TCGA COAD -0.661; TCGA HNSC -0.354; TCGA KIRC -0.245; TCGA LIHC -0.658; TCGA LUAD -0.35; TCGA LUSC -0.492; TCGA PAAD -0.34; TCGA PRAD -0.207; TCGA SARC -0.386; TCGA THCA -0.437; TCGA STAD -0.512 |
hsa-miR-29a-5p | ATXN1L | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.103; TCGA CESC -0.165; TCGA COAD -0.07; TCGA ESCA -0.079; TCGA HNSC -0.17; TCGA LUAD -0.105; TCGA PAAD -0.108; TCGA PRAD -0.178; TCGA SARC -0.13; TCGA THCA -0.229; TCGA STAD -0.096 |
hsa-miR-29a-5p | C14orf132 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.329; TCGA BRCA -0.251; TCGA CESC -0.225; TCGA COAD -0.86; TCGA ESCA -0.765; TCGA HNSC -0.189; TCGA LIHC -0.449; TCGA LUAD -0.357; TCGA LUSC -0.233; TCGA PRAD -0.136; TCGA SARC -0.365; TCGA THCA -0.261; TCGA STAD -0.889 |
hsa-miR-29a-5p | STON1 | 11 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.222; TCGA COAD -0.801; TCGA ESCA -0.696; TCGA HNSC -0.145; TCGA LIHC -0.378; TCGA LUAD -0.334; TCGA LUSC -0.232; TCGA PAAD -0.396; TCGA PRAD -0.234; TCGA SARC -0.574; TCGA THCA -0.281 |
hsa-miR-29a-5p | ZNF585B | 9 cancers: BLCA; COAD; HNSC; KIRP; LIHC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.157; TCGA COAD -0.103; TCGA HNSC -0.125; TCGA KIRP -0.225; TCGA LIHC -0.257; TCGA PRAD -0.134; TCGA SARC -0.172; TCGA THCA -0.229; TCGA STAD -0.328 |
hsa-miR-29a-5p | DENND1B | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.105; TCGA CESC -0.214; TCGA COAD -0.129; TCGA HNSC -0.295; TCGA KIRP -0.404; TCGA LGG -0.089; TCGA LIHC -0.169; TCGA LUAD -0.066; TCGA PRAD -0.262; TCGA THCA -0.266 |
hsa-miR-29a-5p | EXOC5 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.069; TCGA CESC -0.139; TCGA COAD -0.07; TCGA ESCA -0.102; TCGA HNSC -0.088; TCGA LIHC -0.097; TCGA LUAD -0.129; TCGA PRAD -0.124; TCGA SARC -0.082; TCGA THCA -0.163; TCGA STAD -0.092; TCGA UCEC -0.094 |
hsa-miR-29a-5p | ARHGEF12 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.189; TCGA CESC -0.09; TCGA COAD -0.087; TCGA HNSC -0.178; TCGA KIRP -0.135; TCGA LUAD -0.125; TCGA PAAD -0.146; TCGA PRAD -0.14; TCGA SARC -0.144; TCGA THCA -0.12; TCGA STAD -0.091 |
hsa-miR-29a-5p | THRB | 9 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.464; TCGA BRCA -0.267; TCGA COAD -0.473; TCGA HNSC -0.332; TCGA LIHC -0.15; TCGA LUAD -0.202; TCGA SARC -0.395; TCGA THCA -0.13; TCGA STAD -0.489 |
hsa-miR-29a-5p | SLC23A2 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.197; TCGA COAD -0.124; TCGA ESCA -0.151; TCGA HNSC -0.112; TCGA KIRC -0.067; TCGA LUAD -0.064; TCGA PRAD -0.06; TCGA SARC -0.145; TCGA THCA -0.114; TCGA STAD -0.171 |
hsa-miR-29a-5p | CPEB2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.149; TCGA BRCA -0.182; TCGA COAD -0.094; TCGA ESCA -0.175; TCGA HNSC -0.146; TCGA KIRC -0.166; TCGA LUAD -0.064; TCGA PRAD -0.146; TCGA SARC -0.165; TCGA THCA -0.063; TCGA STAD -0.198 |
hsa-miR-29a-5p | MFSD6 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.118; TCGA CESC -0.171; TCGA ESCA -0.148; TCGA HNSC -0.235; TCGA KIRP -0.167; TCGA LIHC -0.218; TCGA PRAD -0.228; TCGA SARC -0.231; TCGA THCA -0.053 |
hsa-miR-29a-5p | BCLAF1 | 10 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.106; TCGA CESC -0.075; TCGA HNSC -0.075; TCGA KIRP -0.12; TCGA LUAD -0.125; TCGA LUSC -0.067; TCGA PRAD -0.103; TCGA SARC -0.06; TCGA THCA -0.071; TCGA UCEC -0.066 |
hsa-miR-29a-5p | NR2F2 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.184; TCGA BRCA -0.105; TCGA COAD -0.255; TCGA HNSC -0.118; TCGA KIRP -0.232; TCGA LIHC -0.102; TCGA LUAD -0.17; TCGA PAAD -0.324; TCGA PRAD -0.085; TCGA SARC -0.365; TCGA THCA -0.145; TCGA STAD -0.259 |
hsa-miR-29a-5p | LDB2 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; PAAD; THCA; STAD | miRNATAP | TCGA BLCA -0.188; TCGA BRCA -0.239; TCGA COAD -0.495; TCGA HNSC -0.182; TCGA KIRC -0.455; TCGA LUAD -0.255; TCGA PAAD -0.279; TCGA THCA -0.164; TCGA STAD -0.356 |
hsa-miR-29a-5p | TSHZ1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LIHC; PAAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.233; TCGA BRCA -0.067; TCGA COAD -0.153; TCGA ESCA -0.299; TCGA HNSC -0.224; TCGA KIRC -0.238; TCGA LGG -0.097; TCGA LIHC -0.093; TCGA PAAD -0.173; TCGA SARC -0.256; TCGA THCA -0.176; TCGA STAD -0.317 |
hsa-miR-29a-5p | GTF2A1 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.241; TCGA CESC -0.42; TCGA COAD -0.136; TCGA HNSC -0.385; TCGA KIRP -0.493; TCGA LIHC -0.211; TCGA LUAD -0.211; TCGA PRAD -0.342; TCGA SARC -0.163; TCGA THCA -0.508 |
hsa-miR-29a-5p | C3orf58 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.353; TCGA CESC -0.422; TCGA COAD -0.065; TCGA ESCA -0.36; TCGA HNSC -0.212; TCGA KIRC -0.128; TCGA KIRP -0.142; TCGA LUAD -0.255; TCGA LUSC -0.187; TCGA PAAD -0.165; TCGA PRAD -0.073; TCGA SARC -0.301; TCGA THCA -0.093; TCGA STAD -0.147; TCGA UCEC -0.178 |
hsa-miR-29a-5p | RARB | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.318; TCGA CESC -0.303; TCGA COAD -0.457; TCGA ESCA -0.629; TCGA HNSC -0.429; TCGA LUAD -0.316; TCGA LUSC -0.212; TCGA PRAD -0.077; TCGA SARC -0.161; TCGA THCA -0.339; TCGA STAD -0.444; TCGA UCEC -0.138 |
hsa-miR-29a-5p | HOXD3 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUSC; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.146; TCGA BRCA -0.308; TCGA CESC -0.307; TCGA COAD -0.337; TCGA KIRC -0.18; TCGA KIRP -0.616; TCGA LUSC -0.317; TCGA SARC -0.278; TCGA STAD -0.41; TCGA UCEC -0.184 |
hsa-miR-29a-5p | ZNF557 | 9 cancers: BLCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; SARC; THCA | miRNATAP | TCGA BLCA -0.105; TCGA CESC -0.087; TCGA ESCA -0.106; TCGA LGG -0.118; TCGA LIHC -0.157; TCGA LUAD -0.051; TCGA LUSC -0.108; TCGA SARC -0.066; TCGA THCA -0.057 |
hsa-miR-29a-5p | MAGI1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.435; TCGA BRCA -0.081; TCGA CESC -0.175; TCGA COAD -0.098; TCGA HNSC -0.243; TCGA KIRP -0.173; TCGA LIHC -0.109; TCGA LUAD -0.193; TCGA PAAD -0.192; TCGA PRAD -0.072; TCGA SARC -0.387; TCGA THCA -0.307 |
hsa-miR-29a-5p | ZNF516 | 9 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; THCA; STAD | MirTarget; mirMAP | TCGA BRCA -0.126; TCGA ESCA -0.252; TCGA HNSC -0.21; TCGA KIRC -0.107; TCGA LGG -0.122; TCGA LUSC -0.111; TCGA PRAD -0.3; TCGA THCA -0.096; TCGA STAD -0.307 |
hsa-miR-29a-5p | F2R | 9 cancers: BRCA; COAD; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; THCA | MirTarget | TCGA BRCA -0.163; TCGA COAD -0.458; TCGA HNSC -0.155; TCGA KIRC -0.236; TCGA LGG -0.23; TCGA LIHC -0.148; TCGA LUAD -0.256; TCGA PAAD -0.302; TCGA THCA -0.214 |
hsa-miR-29a-5p | SNCAIP | 9 cancers: BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; STAD | mirMAP | TCGA BRCA -0.156; TCGA COAD -0.332; TCGA ESCA -0.577; TCGA HNSC -0.153; TCGA LGG -0.275; TCGA LUAD -0.183; TCGA LUSC -0.155; TCGA PRAD -0.246; TCGA STAD -0.308 |
hsa-miR-29a-5p | NUAK1 | 11 cancers: BRCA; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.191; TCGA COAD -0.44; TCGA ESCA -0.193; TCGA KIRP -0.166; TCGA LIHC -0.202; TCGA LUAD -0.258; TCGA LUSC -0.198; TCGA PAAD -0.338; TCGA PRAD -0.197; TCGA THCA -0.283; TCGA STAD -0.142 |
hsa-miR-29a-5p | OSBPL6 | 10 cancers: BRCA; COAD; ESCA; KIRP; LGG; LIHC; LUAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.159; TCGA COAD -0.717; TCGA ESCA -1.068; TCGA KIRP -0.456; TCGA LGG -0.114; TCGA LIHC -0.347; TCGA LUAD -0.227; TCGA SARC -0.153; TCGA THCA -0.473; TCGA STAD -0.634 |
hsa-miR-29a-5p | PGR | 9 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BRCA -0.438; TCGA COAD -0.906; TCGA ESCA -0.508; TCGA HNSC -0.205; TCGA LUAD -0.278; TCGA LUSC -0.252; TCGA PRAD -0.21; TCGA SARC -0.799; TCGA STAD -0.912 |
hsa-miR-29a-5p | ELK3 | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.068; TCGA COAD -0.391; TCGA HNSC -0.192; TCGA KIRC -0.204; TCGA KIRP -0.433; TCGA LIHC -0.194; TCGA LUAD -0.086; TCGA PRAD -0.252; TCGA THCA -0.216; TCGA STAD -0.105 |
hsa-miR-29a-5p | ADAM23 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.224; TCGA CESC -0.622; TCGA COAD -0.871; TCGA ESCA -1.252; TCGA HNSC -0.469; TCGA KIRP -0.437; TCGA LIHC -0.478; TCGA LUAD -0.381; TCGA PAAD -0.476; TCGA PRAD -0.229; TCGA THCA -0.309; TCGA STAD -0.639 |
hsa-miR-29a-5p | PRRX1 | 11 cancers: BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.097; TCGA COAD -0.673; TCGA ESCA -0.478; TCGA HNSC -0.151; TCGA LGG -0.136; TCGA LUAD -0.098; TCGA LUSC -0.221; TCGA PAAD -0.586; TCGA PRAD -0.156; TCGA THCA -0.246; TCGA STAD -0.206 |
hsa-miR-29a-5p | CD93 | 11 cancers: BRCA; COAD; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.118; TCGA COAD -0.479; TCGA HNSC -0.223; TCGA KIRC -0.379; TCGA LGG -0.151; TCGA LIHC -0.168; TCGA LUAD -0.224; TCGA PAAD -0.339; TCGA PRAD -0.096; TCGA THCA -0.187; TCGA STAD -0.159 |
hsa-miR-29a-5p | RBMS3 | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.241; TCGA COAD -0.681; TCGA ESCA -0.428; TCGA HNSC -0.218; TCGA KIRC -0.181; TCGA KIRP -0.243; TCGA LUAD -0.233; TCGA PAAD -0.473; TCGA PRAD -0.304; TCGA SARC -0.138; TCGA THCA -0.235; TCGA STAD -0.636 |
hsa-miR-29a-5p | ZNF385D | 11 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.119; TCGA COAD -1.038; TCGA ESCA -0.563; TCGA HNSC -0.199; TCGA LUAD -0.2; TCGA LUSC -0.307; TCGA PAAD -0.816; TCGA PRAD -0.147; TCGA SARC -0.276; TCGA THCA -0.272; TCGA STAD -0.633 |
hsa-miR-29a-5p | FSTL1 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.107; TCGA COAD -0.547; TCGA ESCA -0.26; TCGA HNSC -0.156; TCGA KIRC -0.237; TCGA KIRP -0.24; TCGA LIHC -0.192; TCGA LUAD -0.239; TCGA LUSC -0.25; TCGA PAAD -0.421; TCGA PRAD -0.135; TCGA THCA -0.15; TCGA STAD -0.356 |
hsa-miR-29a-5p | FIBIN | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BRCA -0.154; TCGA COAD -0.696; TCGA ESCA -0.757; TCGA HNSC -0.358; TCGA KIRP -0.52; TCGA LIHC -0.321; TCGA LUAD -0.328; TCGA LUSC -0.361; TCGA PAAD -0.56; TCGA THCA -0.604; TCGA STAD -0.361 |
hsa-miR-29a-5p | FAM26E | 10 cancers: BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BRCA -0.138; TCGA COAD -0.612; TCGA ESCA -0.277; TCGA HNSC -0.149; TCGA LIHC -0.134; TCGA LUAD -0.259; TCGA LUSC -0.252; TCGA PAAD -0.353; TCGA THCA -0.232; TCGA STAD -0.2 |
hsa-miR-29a-5p | FLRT2 | 9 cancers: BRCA; COAD; ESCA; LIHC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.193; TCGA COAD -0.79; TCGA ESCA -0.742; TCGA LIHC -0.286; TCGA LUAD -0.155; TCGA PAAD -1.015; TCGA PRAD -0.144; TCGA THCA -0.26; TCGA STAD -0.512 |
hsa-miR-29a-5p | SV2B | 10 cancers: BRCA; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.13; TCGA COAD -0.943; TCGA ESCA -0.851; TCGA HNSC -0.277; TCGA LIHC -0.386; TCGA LUAD -0.396; TCGA PAAD -0.726; TCGA PRAD -0.249; TCGA THCA -0.428; TCGA STAD -0.598 |
hsa-miR-29a-5p | CYS1 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD | mirMAP | TCGA BRCA -0.245; TCGA COAD -0.672; TCGA ESCA -0.591; TCGA HNSC -0.28; TCGA KIRP -0.22; TCGA LUAD -0.295; TCGA LUSC -0.312; TCGA PAAD -0.87; TCGA STAD -0.757 |
hsa-miR-29a-5p | OLFML2A | 9 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; PRAD; STAD | miRNATAP | TCGA BRCA -0.183; TCGA COAD -0.377; TCGA ESCA -0.265; TCGA KIRC -0.694; TCGA KIRP -0.33; TCGA LIHC -0.309; TCGA LUAD -0.168; TCGA PRAD -0.144; TCGA STAD -0.361 |
hsa-miR-29a-5p | CRKL | 9 cancers: CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; THCA | MirTarget | TCGA CESC -0.102; TCGA ESCA -0.142; TCGA HNSC -0.116; TCGA KIRP -0.148; TCGA LGG -0.118; TCGA LIHC -0.065; TCGA LUAD -0.081; TCGA PRAD -0.062; TCGA THCA -0.078 |
hsa-miR-29a-5p | SUZ12 | 9 cancers: CESC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA CESC -0.109; TCGA KIRP -0.137; TCGA LGG -0.071; TCGA LIHC -0.096; TCGA LUAD -0.083; TCGA PRAD -0.167; TCGA SARC -0.122; TCGA THCA -0.1; TCGA UCEC -0.126 |
hsa-miR-29a-5p | ZBTB5 | 12 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA CESC -0.103; TCGA ESCA -0.145; TCGA HNSC -0.066; TCGA KIRC -0.078; TCGA KIRP -0.14; TCGA LGG -0.129; TCGA LIHC -0.165; TCGA LUSC -0.133; TCGA PRAD -0.06; TCGA SARC -0.171; TCGA THCA -0.126; TCGA UCEC -0.063 |
hsa-miR-29a-5p | SERTAD4 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; SARC; THCA; STAD | MirTarget; mirMAP | TCGA CESC -0.572; TCGA COAD -0.855; TCGA ESCA -0.543; TCGA HNSC -0.307; TCGA KIRP -0.402; TCGA PAAD -0.345; TCGA PRAD -0.434; TCGA SARC -0.709; TCGA THCA -0.374; TCGA STAD -0.732 |
hsa-miR-29a-5p | WWTR1 | 12 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA CESC -0.197; TCGA COAD -0.659; TCGA ESCA -0.424; TCGA HNSC -0.263; TCGA KIRC -0.126; TCGA KIRP -0.309; TCGA LUAD -0.11; TCGA PAAD -0.36; TCGA PRAD -0.26; TCGA SARC -0.16; TCGA THCA -0.38; TCGA STAD -0.526 |
hsa-miR-29a-5p | ERC1 | 11 cancers: CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA CESC -0.118; TCGA COAD -0.146; TCGA ESCA -0.239; TCGA HNSC -0.164; TCGA LIHC -0.168; TCGA LUAD -0.144; TCGA LUSC -0.105; TCGA PRAD -0.135; TCGA SARC -0.162; TCGA THCA -0.214; TCGA STAD -0.157 |
hsa-miR-29a-5p | ATRN | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PAAD; PRAD; THCA | mirMAP | TCGA CESC -0.139; TCGA COAD -0.164; TCGA ESCA -0.213; TCGA HNSC -0.149; TCGA KIRP -0.246; TCGA LIHC -0.248; TCGA LUAD -0.123; TCGA PAAD -0.161; TCGA PRAD -0.108; TCGA THCA -0.203 |
hsa-miR-29a-5p | OSBPL8 | 10 cancers: CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; THCA; STAD | mirMAP | TCGA CESC -0.083; TCGA COAD -0.138; TCGA HNSC -0.138; TCGA KIRP -0.125; TCGA LGG -0.078; TCGA LIHC -0.139; TCGA LUAD -0.197; TCGA PRAD -0.177; TCGA THCA -0.173; TCGA STAD -0.092 |
hsa-miR-29a-5p | FMO2 | 10 cancers: CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA CESC -0.579; TCGA COAD -0.71; TCGA ESCA -0.617; TCGA HNSC -0.41; TCGA LUAD -0.383; TCGA PAAD -0.86; TCGA PRAD -0.321; TCGA SARC -0.444; TCGA THCA -0.391; TCGA STAD -0.597 |
hsa-miR-29a-5p | SLC30A4 | 11 cancers: CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA CESC -0.262; TCGA COAD -0.353; TCGA ESCA -0.181; TCGA HNSC -0.358; TCGA LIHC -0.382; TCGA LUAD -0.23; TCGA LUSC -0.184; TCGA PRAD -0.277; TCGA SARC -0.205; TCGA THCA -0.559; TCGA STAD -0.248 |
hsa-miR-29a-5p | ATF6 | 11 cancers: CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA CESC -0.074; TCGA COAD -0.081; TCGA HNSC -0.144; TCGA KIRP -0.25; TCGA LIHC -0.094; TCGA LUAD -0.096; TCGA LUSC -0.082; TCGA PAAD -0.13; TCGA PRAD -0.18; TCGA SARC -0.135; TCGA THCA -0.196 |
hsa-miR-29a-5p | KLF12 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; SARC; STAD | mirMAP | TCGA CESC -0.206; TCGA COAD -0.483; TCGA ESCA -0.306; TCGA HNSC -0.12; TCGA KIRP -0.138; TCGA LGG -0.157; TCGA LUAD -0.187; TCGA LUSC -0.196; TCGA SARC -0.145; TCGA STAD -0.379 |
hsa-miR-29a-5p | CDC73 | 9 cancers: CESC; COAD; HNSC; KIRP; LUAD; PRAD; SARC; THCA; UCEC | mirMAP; miRNATAP | TCGA CESC -0.104; TCGA COAD -0.054; TCGA HNSC -0.076; TCGA KIRP -0.167; TCGA LUAD -0.077; TCGA PRAD -0.144; TCGA SARC -0.109; TCGA THCA -0.149; TCGA UCEC -0.072 |
hsa-miR-29a-5p | SAMD8 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUAD; PRAD; THCA; STAD | mirMAP | TCGA CESC -0.206; TCGA COAD -0.089; TCGA ESCA -0.134; TCGA HNSC -0.17; TCGA KIRP -0.16; TCGA LUAD -0.13; TCGA PRAD -0.196; TCGA THCA -0.205; TCGA STAD -0.189 |
hsa-miR-29a-5p | WASF2 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; THCA; STAD | mirMAP | TCGA CESC -0.139; TCGA COAD -0.066; TCGA ESCA -0.177; TCGA HNSC -0.156; TCGA KIRC -0.071; TCGA LUAD -0.085; TCGA PRAD -0.121; TCGA THCA -0.058; TCGA STAD -0.105 |
hsa-miR-29a-5p | CHML | 9 cancers: CESC; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; THCA; UCEC | mirMAP | TCGA CESC -0.131; TCGA HNSC -0.078; TCGA KIRC -0.144; TCGA KIRP -0.311; TCGA LIHC -0.22; TCGA PRAD -0.12; TCGA SARC -0.32; TCGA THCA -0.168; TCGA UCEC -0.122 |
hsa-miR-29a-5p | TRPS1 | 9 cancers: CESC; COAD; ESCA; HNSC; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA CESC -0.422; TCGA COAD -0.585; TCGA ESCA -0.632; TCGA HNSC -0.245; TCGA LUSC -0.13; TCGA PRAD -0.158; TCGA THCA -0.127; TCGA STAD -0.502; TCGA UCEC -0.131 |
hsa-miR-29a-5p | UBE2Q2 | 9 cancers: COAD; ESCA; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA COAD -0.213; TCGA ESCA -0.269; TCGA KIRP -0.109; TCGA LGG -0.082; TCGA LUAD -0.052; TCGA PAAD -0.138; TCGA PRAD -0.105; TCGA THCA -0.085; TCGA STAD -0.32 |
hsa-miR-29a-5p | ANTXR1 | 13 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA COAD -0.801; TCGA ESCA -0.442; TCGA HNSC -0.268; TCGA KIRC -0.184; TCGA KIRP -0.395; TCGA LGG -0.144; TCGA LIHC -0.244; TCGA LUAD -0.286; TCGA LUSC -0.283; TCGA PAAD -0.36; TCGA PRAD -0.23; TCGA THCA -0.342; TCGA STAD -0.311 |
hsa-miR-29a-5p | SFRP1 | 10 cancers: COAD; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -1.016; TCGA ESCA -1.182; TCGA KIRP -0.692; TCGA LUAD -0.549; TCGA LUSC -0.427; TCGA PAAD -0.603; TCGA PRAD -0.157; TCGA SARC -0.585; TCGA THCA -0.581; TCGA STAD -1.292 |
hsa-miR-29a-5p | QKI | 9 cancers: COAD; ESCA; HNSC; KIRP; LGG; LUAD; PRAD; THCA; STAD | mirMAP | TCGA COAD -0.499; TCGA ESCA -0.321; TCGA HNSC -0.083; TCGA KIRP -0.135; TCGA LGG -0.066; TCGA LUAD -0.164; TCGA PRAD -0.1; TCGA THCA -0.169; TCGA STAD -0.343 |
hsa-miR-29a-5p | BICC1 | 10 cancers: COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA COAD -0.853; TCGA ESCA -0.425; TCGA HNSC -0.552; TCGA KIRP -0.493; TCGA LUAD -0.371; TCGA LUSC -0.322; TCGA PAAD -0.801; TCGA PRAD -0.449; TCGA THCA -0.466; TCGA STAD -0.265 |
hsa-miR-29a-5p | DST | 9 cancers: COAD; ESCA; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA COAD -0.296; TCGA ESCA -0.27; TCGA LIHC -0.168; TCGA LUAD -0.189; TCGA PAAD -0.17; TCGA PRAD -0.167; TCGA SARC -0.145; TCGA STAD -0.501; TCGA UCEC -0.195 |
hsa-miR-29a-5p | RNF152 | 9 cancers: COAD; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.351; TCGA ESCA -0.583; TCGA LUAD -0.271; TCGA LUSC -0.289; TCGA PAAD -0.316; TCGA PRAD -0.244; TCGA SARC -0.407; TCGA THCA -0.305; TCGA STAD -0.236 |
hsa-miR-29a-5p | GJC1 | 10 cancers: COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.483; TCGA KIRC -0.597; TCGA KIRP -0.289; TCGA LIHC -0.291; TCGA LUAD -0.162; TCGA LUSC -0.301; TCGA PRAD -0.104; TCGA SARC -0.219; TCGA THCA -0.129; TCGA STAD -0.633 |
hsa-miR-29a-5p | HIVEP2 | 9 cancers: COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA COAD -0.135; TCGA ESCA -0.141; TCGA HNSC -0.203; TCGA KIRP -0.12; TCGA LUAD -0.076; TCGA PAAD -0.178; TCGA PRAD -0.093; TCGA THCA -0.176; TCGA STAD -0.145 |
hsa-miR-29a-5p | CSRNP3 | 9 cancers: ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA ESCA -0.657; TCGA HNSC -0.503; TCGA KIRP -0.248; TCGA LUAD -0.373; TCGA LUSC -0.328; TCGA PAAD -0.384; TCGA PRAD -0.379; TCGA THCA -0.337; TCGA STAD -0.681 |
Enriched cancer pathways of putative targets